Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References FTP Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:carboxamidine
go back to main search page
Accession:CHEBI:35359 term browser browse the term
Definition:Compounds having the structure RC(=NR)NR2. The term is used as a suffix in systematic nomenclature to denote the -C(=NH)NH2 group including its carbon atom.
Synonyms:related_synonym: Amidines;   carboxamidines
 xref: KEGG:C06060

show annotations for term's descendants           Sort by:
 
(E)-thiamethoxam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ANXA10 annexin A10 increases expression EXP Thiamethoxam results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr 4:168,092,525...168,187,736
Ensembl chr 4:168,092,537...168,187,736 		JBrowse link
G AR androgen receptor affects binding EXP Thiamethoxam binds to AR protein CTD PMID:31550567 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619 		JBrowse link
G ARG1 arginase 1 decreases expression EXP Thiamethoxam results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332 		JBrowse link
G CHRNB2 cholinergic receptor nicotinic beta 2 subunit multiple interactions ISO Thiamethoxam results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein] CTD PMID:16981889 NCBI chr 1:154,567,778...154,584,708
Ensembl chr 1:154,567,778...154,580,013 		JBrowse link
G CYP19A1 cytochrome P450 family 19 subfamily A member 1 increases activity
increases expression		 EXP Thiamethoxam results in increased activity of CYP19A1 protein
Thiamethoxam results in increased expression of CYP19A1 mRNA		 CTD PMID:26464060 PMID:28750898 NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601 		JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 decreases expression EXP Thiamethoxam results in decreased expression of CYP2C19 protein CTD PMID:32194361 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions EXP [NADP co-treated with CYP3A4 protein] results in increased activity of Thiamethoxam CTD PMID:16153789 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G CYP3A7 cytochrome P450 family 3 subfamily A member 7 multiple interactions
increases expression		 EXP Estriol inhibits the reaction [Thiamethoxam results in increased expression of CYP3A7] CTD PMID:28750898 NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196 		JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163 		JBrowse link
G ESR1 estrogen receptor 1 affects binding EXP Thiamethoxam binds to ESR1 protein CTD PMID:31550567 NCBI chr 6:151,654,148...152,129,619
Ensembl chr 6:151,656,691...152,129,619 		JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 decreases expression EXP Thiamethoxam results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438 		JBrowse link
G GPT glutamic--pyruvic transaminase decreases activity ISO Thiamethoxam results in decreased activity of GPT protein CTD PMID:29197058 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions
decreases activity		 ISO [Thiamethoxam metabolite results in decreased activity of NOS2 protein] which results in increased chemical synthesis of Formaldehyde CTD PMID:29197058 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G S100P S100 calcium binding protein P increases expression EXP Thiamethoxam results in increased expression of S100P mRNA CTD PMID:32194361 NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170 		JBrowse link
G SLC22A2 solute carrier family 22 member 2 decreases activity EXP Thiamethoxam results in decreased activity of SLC22A2 protein CTD PMID:31364238 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638 		JBrowse link
G THRA thyroid hormone receptor alpha affects binding EXP Thiamethoxam binds to THRA protein CTD PMID:31550567 NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867 		JBrowse link
G TNNT2 troponin T2, cardiac type increases secretion
multiple interactions		 ISO Thiamethoxam results in increased secretion of TNNT2 protein
fenugreek seed meal inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]; Polysaccharides inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]		 CTD PMID:30520268 NCBI chr 1:201,359,014...201,377,828
Ensembl chr 1:201,359,008...201,377,764 		JBrowse link
acetamiprid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACTRT2 actin related protein T2 decreases expression ISO acetamiprid results in decreased expression of ACTRT2 mRNA CTD PMID:27782041 NCBI chr 1:3,021,467...3,022,903
Ensembl chr 1:3,021,467...3,022,903 		JBrowse link
G ASAP2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 increases expression ISO acetamiprid results in increased expression of ASAP2 mRNA CTD PMID:27782041 NCBI chr 2:9,206,812...9,405,678
Ensembl chr 2:9,206,765...9,405,683 		JBrowse link
G B3GNT9 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 increases expression ISO acetamiprid results in increased expression of B3GNT9 mRNA CTD PMID:27782041 NCBI chr16:67,148,104...67,150,998
Ensembl chr16:67,148,104...67,150,998 		JBrowse link
G CACNA1H calcium voltage-gated channel subunit alpha1 H increases expression ISO acetamiprid results in increased expression of CACNA1H mRNA CTD PMID:27782041 NCBI chr16:1,153,106...1,221,769
Ensembl chr16:1,153,106...1,221,771 		JBrowse link
G CACNG1 calcium voltage-gated channel auxiliary subunit gamma 1 decreases expression ISO acetamiprid results in decreased expression of CACNG1 mRNA CTD PMID:27782041 NCBI chr17:67,044,554...67,056,797
Ensembl chr17:67,044,554...67,056,797 		JBrowse link
G CARD11 caspase recruitment domain family member 11 increases expression ISO acetamiprid results in increased expression of CARD11 mRNA CTD PMID:27782041 NCBI chr 7:2,906,142...3,043,867
Ensembl chr 7:2,906,141...3,043,945
Ensembl chr 7:2,906,141...3,043,945 		JBrowse link
G CAT catalase decreases activity EXP acetamiprid results in decreased activity of CAT protein CTD PMID:31935421 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CHRNA4 cholinergic receptor nicotinic alpha 4 subunit decreases expression ISO acetamiprid results in decreased expression of CHRNA4 mRNA CTD PMID:30103633 NCBI chr20:63,343,223...63,375,471
Ensembl chr20:63,343,223...63,378,401 		JBrowse link
G CHRNA7 cholinergic receptor nicotinic alpha 7 subunit decreases expression ISO acetamiprid results in decreased expression of CHRNA7 mRNA CTD PMID:30103633 NCBI chr15:32,030,462...32,173,018
Ensembl chr15:31,923,438...32,173,018 		JBrowse link
G CHRNB2 cholinergic receptor nicotinic beta 2 subunit decreases expression
multiple interactions		 ISO acetamiprid results in decreased expression of CHRNB2
acetamiprid results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]; acetamiprid results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]		 CTD PMID:16981889 PMID:25459289 PMID:27669271 NCBI chr 1:154,567,778...154,584,708
Ensembl chr 1:154,567,778...154,580,013 		JBrowse link
G CYP11A1 cytochrome P450 family 11 subfamily A member 1 decreases expression
multiple interactions		 ISO acetamiprid results in decreased expression of CYP11A1 mRNA; acetamiprid results in decreased expression of CYP11A1 protein
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein]		 CTD PMID:28395332 PMID:30103633 NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646 		JBrowse link
G CYP17A1 cytochrome P450 family 17 subfamily A member 1 decreases expression ISO acetamiprid results in decreased expression of CYP17A1 mRNA CTD PMID:30103633 NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472 		JBrowse link
G DCDC2 doublecortin domain containing 2 increases expression
decreases expression		 ISO acetamiprid results in increased expression of DCDC2 mRNA
acetamiprid results in decreased expression of DCDC2 mRNA		 CTD PMID:27782041 NCBI chr 6:24,171,755...24,383,292
Ensembl chr 6:24,171,755...24,358,059 		JBrowse link
G DES desmin decreases expression ISO acetamiprid results in decreased expression of DES mRNA CTD PMID:27782041 NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,734 		JBrowse link
G F2RL2 coagulation factor II thrombin receptor like 2 increases expression ISO acetamiprid results in increased expression of F2RL2 mRNA CTD PMID:27782041 NCBI chr 5:76,615,482...76,623,403
Ensembl chr 5:76,615,482...76,623,413 		JBrowse link
G HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 decreases expression ISO acetamiprid results in decreased expression of HSD17B1 mRNA CTD PMID:30103633 NCBI chr17:42,552,923...42,555,214
Ensembl chr17:42,552,922...42,555,214
Ensembl chr17:42,552,922...42,555,214 		JBrowse link
G HSPB7 heat shock protein family B (small) member 7 decreases expression ISO acetamiprid results in decreased expression of HSPB7 mRNA CTD PMID:27782041 NCBI chr 1:16,014,029...16,019,594
Ensembl chr 1:16,014,028...16,019,594 		JBrowse link
G IQCF1 IQ motif containing F1 decreases expression ISO acetamiprid results in decreased expression of IQCF1 mRNA CTD PMID:27782041 NCBI chr 3:51,894,876...51,903,353
Ensembl chr 3:51,894,876...51,903,353 		JBrowse link
G LHB luteinizing hormone subunit beta multiple interactions
increases expression		 ISO Vitamin E inhibits the reaction [acetamiprid results in increased expression of LHB protein] CTD PMID:28395332 NCBI chr19:49,015,980...49,017,091
Ensembl chr19:49,015,980...49,017,090
Ensembl chr19:49,015,980...49,017,090 		JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor decreases expression ISO acetamiprid results in decreased expression of LHR mRNA CTD PMID:30103633 NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730 		JBrowse link
G LMOD2 leiomodin 2 decreases expression ISO acetamiprid results in decreased expression of LMOD2 mRNA CTD PMID:27782041 NCBI chr 7:123,655,866...123,664,290
Ensembl chr 7:123,655,866...123,664,290 		JBrowse link
G MB myoglobin decreases expression ISO acetamiprid results in decreased expression of MB mRNA CTD PMID:27782041 NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951 		JBrowse link
G MCMDC2 minichromosome maintenance domain containing 2 increases expression ISO acetamiprid results in increased expression of MCMDC2 mRNA CTD PMID:27782041 NCBI chr 8:66,870,757...66,926,436
Ensembl chr 8:66,870,749...66,922,048 		JBrowse link
G MKI67 marker of proliferation Ki-67 decreases expression ISO acetamiprid results in decreased expression of MKI67 mRNA CTD PMID:30103633 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423 		JBrowse link
G MYOG myogenin decreases expression ISO acetamiprid results in decreased expression of MYOG mRNA CTD PMID:27782041 NCBI chr 1:203,083,129...203,086,012
Ensembl chr 1:203,083,129...203,086,012 		JBrowse link
G NAGS N-acetylglutamate synthase decreases expression ISO acetamiprid results in decreased expression of NAGS mRNA CTD PMID:27782041 NCBI chr17:44,004,546...44,009,068
Ensembl chr17:44,004,622...44,009,068 		JBrowse link
G NAPB NSF attachment protein beta increases expression ISO acetamiprid results in increased expression of NAPB mRNA CTD PMID:27782041 NCBI chr20:23,374,522...23,421,498
Ensembl chr20:23,374,519...23,421,519 		JBrowse link
G NDUFAF2 NADH:ubiquinone oxidoreductase complex assembly factor 2 decreases expression ISO acetamiprid results in decreased expression of NDUFAF2 mRNA CTD PMID:27782041 NCBI chr 5:60,945,205...61,153,026
Ensembl chr 5:60,945,205...61,153,026
Ensembl chr 5:60,945,205...61,153,026 		JBrowse link
G PHF21B PHD finger protein 21B increases expression ISO acetamiprid results in increased expression of PHF21B mRNA CTD PMID:27782041 NCBI chr22:44,881,162...45,010,005
Ensembl chr22:44,881,162...45,010,005 		JBrowse link
G PLAC8 placenta associated 8 increases expression ISO acetamiprid results in increased expression of PLAC8 mRNA CTD PMID:27782041 NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,090,048...83,137,075 		JBrowse link
G SLC22A1 solute carrier family 22 member 1 increases activity EXP acetamiprid results in increased activity of SLC22A1 protein CTD PMID:31364238 NCBI chr 6:160,121,808...160,160,590
Ensembl chr 6:160,121,815...160,158,718 		JBrowse link
G SLC22A2 solute carrier family 22 member 2 decreases activity EXP acetamiprid results in decreased activity of SLC22A2 protein CTD PMID:31364238 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638 		JBrowse link
G SLC22A8 solute carrier family 22 member 8 decreases activity EXP acetamiprid results in decreased activity of SLC22A8 protein CTD PMID:31364238 NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841 		JBrowse link
G SLC45A3 solute carrier family 45 member 3 increases expression ISO acetamiprid results in increased expression of SLC45A3 mRNA CTD PMID:27782041 NCBI chr 1:205,657,851...205,680,509
Ensembl chr 1:205,657,851...205,680,509 		JBrowse link
G SLCO1B3 solute carrier organic anion transporter family member 1B3 decreases expression ISO acetamiprid results in decreased expression of SLCO1B2 mRNA CTD PMID:27782041 NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911 		JBrowse link
G STAR steroidogenic acute regulatory protein multiple interactions
decreases expression		 ISO Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR protein]
acetamiprid results in decreased expression of STAR mRNA; acetamiprid results in decreased expression of STAR protein		 CTD PMID:28395332 PMID:30103633 NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992 		JBrowse link
G TADA2B transcriptional adaptor 2B increases expression ISO acetamiprid results in increased expression of TADA2B mRNA CTD PMID:27782041 NCBI chr 4:7,043,372...7,057,952
Ensembl chr 4:7,041,899...7,057,952 		JBrowse link
G TNNI2 troponin I2, fast skeletal type decreases expression ISO acetamiprid results in decreased expression of TNNI2 mRNA CTD PMID:27782041 NCBI chr11:1,838,981...1,841,678
Ensembl chr11:1,838,981...1,841,680 		JBrowse link
G TOP2A DNA topoisomerase II alpha decreases expression ISO acetamiprid results in decreased expression of TOP2A mRNA CTD PMID:30103633 NCBI chr17:40,388,525...40,417,902
Ensembl chr17:40,388,525...40,417,896 		JBrowse link
G UNC45B unc-45 myosin chaperone B decreases expression ISO acetamiprid results in decreased expression of UNC45B mRNA CTD PMID:27782041 NCBI chr17:35,147,793...35,189,345
Ensembl chr17:35,147,817...35,189,345 		JBrowse link
amitraz term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRA2A adrenoceptor alpha 2A multiple interactions
decreases activity		 ISO
EXP		 [Idazoxan binds to and results in decreased activity of ADRA2A protein] which results in decreased susceptibility to amitraz; amitraz binds to and results in increased activity of ADRA2A protein
amitraz results in decreased activity of ADRA2A protein		 CTD PMID:10582558 PMID:21251949 NCBI chr10:111,077,029...111,080,907
Ensembl chr10:111,077,029...111,080,907 		JBrowse link
G CAT catalase decreases expression
multiple interactions		 ISO amitraz results in decreased expression of CAT protein
KEAP1 protein affects the reaction [amitraz results in decreased expression of CAT protein]		 CTD PMID:31029719 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CGB3 chorionic gonadotropin subunit beta 3 decreases response to substance
multiple interactions		 EXP amitraz results in decreased susceptibility to CGB3 protein
amitraz inhibits the reaction [CGB3 protein results in increased abundance of Progesterone]; Yohimbine inhibits the reaction [amitraz inhibits the reaction [CGB3 protein results in increased abundance of Progesterone]]; Yohimbine inhibits the reaction [amitraz results in decreased susceptibility to CGB3 protein]		 CTD PMID:16085667 NCBI chr19:49,022,869...49,024,333
Ensembl chr19:49,022,869...49,024,333 		JBrowse link
G COMT catechol-O-methyltransferase affects expression
multiple interactions		 ISO amitraz affects the expression of COMT mRNA; amitraz affects the expression of COMT protein
Tamoxifen inhibits the reaction [amitraz affects the expression of COMT mRNA]; Tamoxifen inhibits the reaction [amitraz affects the expression of COMT protein]		 CTD PMID:28463726 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,733...19,969,975
Ensembl chr22:19,941,733...19,969,975
Ensembl chr22:19,941,733...19,969,975 		JBrowse link
G CYP19A1 cytochrome P450 family 19 subfamily A member 1 increases expression ISO amitraz results in increased expression of CYP19A1 mRNA; amitraz results in increased expression of CYP19A1 protein CTD PMID:28463726 NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression ISO amitraz results in increased expression of CYP1A1 protein CTD PMID:15350676 PMID:31029719 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases expression ISO amitraz results in increased expression of CYP1A2 protein CTD PMID:15350676 PMID:31029719 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 increases expression ISO amitraz results in increased expression of CYP2E1 protein CTD PMID:31029719 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220 		JBrowse link
G DBH dopamine beta-hydroxylase increases expression
multiple interactions		 ISO amitraz results in increased expression of DBH mRNA; amitraz results in increased expression of DBH protein
Tamoxifen inhibits the reaction [amitraz results in increased expression of DBH mRNA]; Tamoxifen inhibits the reaction [amitraz results in increased expression of DBH protein]		 CTD PMID:28463726 NCBI chr 9:133,636,363...133,659,329
Ensembl chr 9:133,636,363...133,659,329 		JBrowse link
G DRD2 dopamine receptor D2 multiple interactions ISO amitraz inhibits the reaction [Spiperone binds to DRD2 protein] CTD PMID:2833825 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691 		JBrowse link
G GAD2 glutamate decarboxylase 2 affects expression
multiple interactions		 ISO amitraz affects the expression of GAD2 mRNA
[methylhistaprodifen co-treated with Idazoxan] inhibits the reaction [amitraz affects the expression of GAD2 mRNA]; Idazoxan inhibits the reaction [amitraz affects the expression of GAD2 mRNA]; methylhistaprodifen inhibits the reaction [amitraz affects the expression of GAD2 mRNA]		 CTD PMID:26141220 NCBI chr10:26,216,372...26,304,558
Ensembl chr10:26,216,665...26,304,558 		JBrowse link
G GCG glucagon increases secretion ISO amitraz results in increased secretion of GCG protein CTD PMID:10582558 NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404 		JBrowse link
G GLS glutaminase multiple interactions
increases expression		 ISO [methylhistaprodifen co-treated with Idazoxan] inhibits the reaction [amitraz results in increased expression of GLS mRNA]; methylhistaprodifen inhibits the reaction [amitraz results in increased expression of GLS mRNA] CTD PMID:26141220 NCBI chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552 		JBrowse link
G KEAP1 kelch like ECH associated protein 1 multiple interactions
increases expression		 ISO KEAP1 protein affects the reaction [amitraz results in decreased expression of CAT protein]; KEAP1 protein affects the reaction [amitraz results in decreased expression of NFE2L2 protein]; KEAP1 protein affects the reaction [amitraz results in decreased expression of NQO1 protein]; KEAP1 protein affects the reaction [amitraz results in decreased expression of SOD1 protein]
amitraz results in increased expression of KEAP1 protein		 CTD PMID:31029719 NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558 		JBrowse link
G LHB luteinizing hormone subunit beta increases expression ISO amitraz results in increased expression of LHB protein CTD PMID:16085667 NCBI chr19:49,015,980...49,017,091
Ensembl chr19:49,015,980...49,017,090
Ensembl chr19:49,015,980...49,017,090 		JBrowse link
G MAOA monoamine oxidase A multiple interactions
decreases expression		 ISO Tamoxifen inhibits the reaction [amitraz results in decreased expression of MAOA mRNA]; Tamoxifen inhibits the reaction [amitraz results in decreased expression of MAOA protein]
amitraz results in decreased expression of MAOA mRNA; amitraz results in decreased expression of MAOA protein		 CTD PMID:28463726 NCBI chr  X:43,655,006...43,746,817
Ensembl chr  X:43,654,907...43,746,824 		JBrowse link
G MAOB monoamine oxidase B decreases expression
multiple interactions		 ISO amitraz results in decreased expression of MAOB mRNA; amitraz results in decreased expression of MAOB protein
Tamoxifen inhibits the reaction [amitraz results in decreased expression of MAOB mRNA]; Tamoxifen inhibits the reaction [amitraz results in decreased expression of MAOB protein]		 CTD PMID:28463726 NCBI chr  X:43,766,610...43,882,450
Ensembl chr  X:43,766,610...43,882,450 		JBrowse link
G NFE2L2 nuclear factor, erythroid 2 like 2 decreases expression
multiple interactions		 ISO amitraz results in decreased expression of NFE2L2 protein
KEAP1 protein affects the reaction [amitraz results in decreased expression of NFE2L2 protein]		 CTD PMID:31029719 NCBI chr 2:177,230,303...177,265,131
Ensembl chr 2:177,227,595...177,392,697 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression		 ISO KEAP1 protein affects the reaction [amitraz results in decreased expression of NQO1 protein] CTD PMID:31029719 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G POR cytochrome p450 oxidoreductase increases activity ISO amitraz results in increased activity of POR protein CTD PMID:15350676 NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855 		JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP amitraz inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638 		JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions
decreases expression		 ISO KEAP1 protein affects the reaction [amitraz results in decreased expression of SOD1 protein] CTD PMID:31029719 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,622...31,668,931
Ensembl chr21:31,659,622...31,668,931 		JBrowse link
G TH tyrosine hydroxylase increases expression
multiple interactions		 ISO amitraz results in increased expression of TH mRNA; amitraz results in increased expression of TH protein
Tamoxifen inhibits the reaction [amitraz results in increased expression of TH mRNA]; Tamoxifen inhibits the reaction [amitraz results in increased expression of TH protein]		 CTD PMID:28463726 NCBI chr11:2,163,929...2,174,081
Ensembl chr11:2,163,929...2,171,877
Ensembl chr11:2,163,929...2,171,877 		JBrowse link
benzamidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G EGFR epidermal growth factor receptor decreases activity EXP benzamidine analog results in decreased activity of EGFR protein CTD PMID:15186837 NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628 		JBrowse link
G IGFBP5 insulin like growth factor binding protein 5 decreases degradation ISO benzamidine results in decreased degradation of IGFBP5 protein CTD PMID:8894652 NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549 		JBrowse link
G KLK1 kallikrein 1 multiple interactions EXP benzamidine binds to and results in decreased activity of KLK1 protein CTD PMID:11151026 NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase decreases activity EXP benzamidine analog results in decreased activity of SRC protein CTD PMID:15186837 NCBI chr20:37,344,690...37,406,050
Ensembl chr20:37,344,685...37,406,050 		JBrowse link
clothianidin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA13 ATP binding cassette subfamily A member 13 increases expression EXP clothianidin results in increased expression of ABCA13 mRNA CTD PMID:31626844 NCBI chr 7:48,171,424...48,647,497
Ensembl chr 7:48,171,458...48,647,497 		JBrowse link
G ABCB6 ATP binding cassette subfamily B member 6 (Langereis blood group) decreases expression EXP clothianidin results in decreased expression of ABCB6 mRNA CTD PMID:29044138 NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994 		JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 increases expression EXP clothianidin results in increased expression of ABCC1 mRNA CTD PMID:31626844 NCBI chr16:15,949,616...16,143,062
Ensembl chr16:15,949,577...16,143,074
Ensembl chr16:15,949,577...16,143,074 		JBrowse link
G ABCD2 ATP binding cassette subfamily D member 2 decreases expression EXP clothianidin results in decreased expression of ABCD2 mRNA CTD PMID:31626844 NCBI chr12:39,530,965...39,651,333
Ensembl chr12:39,550,033...39,619,803 		JBrowse link
G ABCD3 ATP binding cassette subfamily D member 3 decreases expression EXP clothianidin results in decreased expression of ABCD3 mRNA CTD PMID:31626844 NCBI chr 1:94,418,086...94,518,663
Ensembl chr 1:94,418,389...94,518,666 		JBrowse link
G ABCG1 ATP binding cassette subfamily G member 1 decreases expression EXP clothianidin results in decreased expression of ABCG1 mRNA CTD PMID:29044138 NCBI chr21:42,199,689...42,304,387
Ensembl chr21:42,199,689...42,297,244 		JBrowse link
G ABHD4 abhydrolase domain containing 4, N-acyl phospholipase B decreases expression EXP clothianidin results in decreased expression of ABHD4 mRNA CTD PMID:31626844 NCBI chr14:22,598,238...22,612,864
Ensembl chr14:22,598,237...22,613,215 		JBrowse link
G ABI3BP ABI family member 3 binding protein decreases expression EXP clothianidin results in decreased expression of ABI3BP mRNA CTD PMID:31626844 NCBI chr 3:100,749,156...100,993,508
Ensembl chr 3:100,749,156...100,993,515 		JBrowse link
G ADCY2 adenylate cyclase 2 increases expression EXP clothianidin results in increased expression of ADCY2 mRNA CTD PMID:31626844 NCBI chr 5:7,396,138...7,830,081
Ensembl chr 5:7,396,138...7,830,081 		JBrowse link
G ADCY4 adenylate cyclase 4 decreases expression EXP clothianidin results in decreased expression of ADCY4 mRNA CTD PMID:29044138 NCBI chr14:24,318,359...24,335,071
Ensembl chr14:24,318,349...24,335,093 		JBrowse link
G ADGRB2 adhesion G protein-coupled receptor B2 decreases expression EXP clothianidin results in decreased expression of ADGRB2 mRNA CTD PMID:31626844 NCBI chr 1:31,727,105...31,764,340
Ensembl chr 1:31,727,117...31,764,893 		JBrowse link
G ADGRF5 adhesion G protein-coupled receptor F5 decreases expression EXP clothianidin results in decreased expression of ADGRF5 mRNA CTD PMID:31626844 NCBI chr 6:46,852,522...46,954,954
Ensembl chr 6:46,852,522...46,954,943 		JBrowse link
G ADGRG6 adhesion G protein-coupled receptor G6 decreases expression EXP clothianidin results in decreased expression of ADGRG6 mRNA CTD PMID:31626844 NCBI chr 6:142,302,007...142,446,261
Ensembl chr 6:142,301,854...142,446,266 		JBrowse link
G ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide multiple interactions EXP [clothianidin co-treated with enilconazole] results in decreased expression of ADH1A mRNA; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in decreased expression of ADH1A mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of ADH1A mRNA CTD PMID:32201337 NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003 		JBrowse link
G ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide decreases expression EXP clothianidin results in decreased expression of ADH1B mRNA CTD PMID:31626844 NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,352,760 		JBrowse link
G ADRB2 adrenoceptor beta 2 decreases expression EXP clothianidin results in decreased expression of ADRB2 mRNA CTD PMID:31626844 NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,825,245...148,828,687
Ensembl chr 5:148,825,245...148,828,687 		JBrowse link
G AGBL3 ATP/GTP binding protein like 3 increases expression EXP clothianidin results in increased expression of AGBL3 mRNA CTD PMID:31626844 NCBI chr 7:134,986,139...135,135,782
Ensembl chr 7:134,986,508...135,147,963 		JBrowse link
G ALMS1-IT1 ALMS1 intronic transcript 1 increases expression EXP clothianidin results in increased expression of ALMS1-IT1 mRNA CTD PMID:29044138 NCBI chr 2:73,457,103...73,459,482
Ensembl chr 2:73,456,764...73,459,482 		JBrowse link
G AMZ1 archaelysin family metallopeptidase 1 increases expression EXP clothianidin results in increased expression of AMZ1 mRNA CTD PMID:31626844 NCBI chr 7:2,679,522...2,765,187
Ensembl chr 7:2,679,522...2,775,500 		JBrowse link
G ANK3 ankyrin 3 decreases expression EXP clothianidin results in decreased expression of ANK3 mRNA CTD PMID:31626844 NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490 		JBrowse link
G ANKRD37 ankyrin repeat domain 37 decreases expression EXP clothianidin results in decreased expression of ANKRD37 mRNA CTD PMID:31626844 NCBI chr 4:185,396,841...185,400,243
Ensembl chr 4:185,396,021...185,400,628 		JBrowse link
G APLF aprataxin and PNKP like factor increases expression EXP clothianidin results in increased expression of APLF mRNA CTD PMID:31626844 NCBI chr 2:68,467,585...68,580,162
Ensembl chr 2:68,467,572...68,655,862 		JBrowse link
G ARHGAP17 Rho GTPase activating protein 17 increases expression EXP clothianidin results in increased expression of ARHGAP17 mRNA CTD PMID:31626844 NCBI chr16:24,919,389...25,015,601
Ensembl chr16:24,919,389...25,015,666 		JBrowse link
G ARHGEF2 Rho/Rac guanine nucleotide exchange factor 2 increases expression EXP clothianidin results in increased expression of ARHGEF2 mRNA CTD PMID:31626844 NCBI chr 1:155,946,851...155,991,262
Ensembl chr 1:155,946,851...156,007,070 		JBrowse link
G ARIH2OS ARIH2 opposite strand lncRNA increases expression EXP clothianidin results in increased expression of ARIH2OS mRNA CTD PMID:31626844 NCBI chr 3:48,917,788...48,919,385
Ensembl chr 3:48,917,782...48,918,823
Ensembl chr 3:48,917,782...48,918,823 		JBrowse link
G ARL11 ADP ribosylation factor like GTPase 11 increases expression EXP clothianidin results in increased expression of ARL11 mRNA CTD PMID:31626844 NCBI chr13:49,628,456...49,633,872
Ensembl chr13:49,628,507...49,633,872 		JBrowse link
G ARL2-SNX15 ARL2-SNX15 readthrough (NMD candidate) decreases expression EXP clothianidin results in decreased expression of ARL2-SNX15 mRNA CTD PMID:31626844 NCBI chr11:65,014,113...65,040,572
Ensembl chr11:65,014,182...65,040,570 		JBrowse link
G ARL6 ADP ribosylation factor like GTPase 6 increases expression EXP clothianidin results in increased expression of ARL6 mRNA CTD PMID:31626844 NCBI chr 3:97,762,581...97,812,585
Ensembl chr 3:97,764,521...97,801,229 		JBrowse link
G ASB11 ankyrin repeat and SOCS box containing 11 increases expression EXP clothianidin results in increased expression of ASB11 mRNA CTD PMID:31626844 NCBI chr  X:15,281,697...15,315,640
Ensembl chr  X:15,281,697...15,315,640 		JBrowse link
G ASPHD1 aspartate beta-hydroxylase domain containing 1 decreases expression EXP clothianidin results in decreased expression of ASPHD1 mRNA CTD PMID:31626844 NCBI chr16:29,900,392...29,920,688
Ensembl chr16:29,900,375...29,919,864 		JBrowse link
G ATP1A2 ATPase Na+/K+ transporting subunit alpha 2 decreases expression EXP clothianidin results in decreased expression of ATP1A2 mRNA CTD PMID:29044138 NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591 		JBrowse link
G ATP23 ATP23 metallopeptidase and ATP synthase assembly factor homolog increases expression EXP clothianidin results in increased expression of XRCC6BP1 mRNA CTD PMID:31626844 NCBI chr12:57,941,567...57,959,148
Ensembl chr12:57,906,039...57,959,148 		JBrowse link
G ATP2B3 ATPase plasma membrane Ca2+ transporting 3 decreases expression EXP clothianidin results in decreased expression of ATP2B3 mRNA CTD PMID:29044138 NCBI chr  X:153,517,642...153,582,929
Ensembl chr  X:153,517,676...153,582,939 		JBrowse link
G ATP6V0D2 ATPase H+ transporting V0 subunit d2 increases expression EXP clothianidin results in increased expression of ATP6V0D2 mRNA CTD PMID:31626844 NCBI chr 8:86,098,910...86,154,225
Ensembl chr 8:85,987,323...86,154,225 		JBrowse link
G AWAT1 acyl-CoA wax alcohol acyltransferase 1 increases expression EXP clothianidin results in increased expression of AWAT1 mRNA CTD PMID:31626844 NCBI chr  X:70,233,489...70,240,661
Ensembl chr  X:70,234,655...70,240,659 		JBrowse link
G AXIN1 axin 1 decreases expression EXP clothianidin results in decreased expression of AXIN1 mRNA CTD PMID:31626844 NCBI chr16:287,440...355,226
Ensembl chr16:287,440...352,723 		JBrowse link
G AZIN2 antizyme inhibitor 2 decreases expression EXP clothianidin results in decreased expression of AZIN2 mRNA CTD PMID:29044138 NCBI chr 1:33,081,152...33,162,288
Ensembl chr 1:33,081,104...33,123,492 		JBrowse link
G BARHL1 BarH like homeobox 1 increases expression EXP clothianidin results in increased expression of BARHL1 mRNA CTD PMID:31626844 NCBI chr 9:132,582,606...132,590,252
Ensembl chr 9:132,582,606...132,590,252 		JBrowse link
G BCR BCR activator of RhoGEF and GTPase decreases expression EXP clothianidin results in decreased expression of BCR mRNA CTD PMID:31626844 NCBI chr22:23,180,509...23,318,037
Ensembl chr22:23,179,704...23,318,037 		JBrowse link
G BICD2 BICD cargo adaptor 2 decreases expression EXP clothianidin results in decreased expression of BICD2 mRNA CTD PMID:31626844 NCBI chr 9:92,711,363...92,764,841
Ensembl chr 9:92,711,363...92,764,833 		JBrowse link
G BRICD5 BRICHOS domain containing 5 decreases expression EXP clothianidin results in decreased expression of BRICD5 mRNA CTD PMID:29044138 NCBI chr16:2,209,253...2,210,863
Ensembl chr16:2,209,253...2,211,950 		JBrowse link
G C10orf99 chromosome 10 open reading frame 99 decreases expression EXP clothianidin results in decreased expression of C10ORF99 mRNA CTD PMID:31626844 NCBI chr10:84,173,764...84,185,294
Ensembl chr10:84,173,801...84,185,294 		JBrowse link
G C15orf32 chromosome 15 putative open reading frame 32 decreases expression EXP clothianidin results in decreased expression of C15ORF32 mRNA CTD PMID:31626844 NCBI chr15:92,471,677...92,501,117
Ensembl chr15:92,471,654...92,501,117 		JBrowse link
G C16orf74 chromosome 16 open reading frame 74 decreases expression EXP clothianidin results in decreased expression of C16ORF74 mRNA CTD PMID:31626844 NCBI chr16:85,707,517...85,751,096
Ensembl chr16:85,690,084...85,751,129 		JBrowse link
G C1orf158 chromosome 1 open reading frame 158 decreases expression EXP clothianidin results in decreased expression of C1ORF158 mRNA CTD PMID:31626844 NCBI chr 1:12,746,200...12,763,699
Ensembl chr 1:12,746,200...12,763,699 		JBrowse link
G C21orf58 chromosome 21 open reading frame 58 decreases expression EXP clothianidin results in decreased expression of C21ORF58 mRNA CTD PMID:31626844 NCBI chr21:46,300,426...46,324,046
Ensembl chr21:46,300,181...46,323,875 		JBrowse link
G C22orf31 chromosome 22 open reading frame 31 decreases expression EXP clothianidin results in decreased expression of C22ORF31 mRNA CTD PMID:31626844 NCBI chr22:29,058,672...29,073,943
Ensembl chr22:29,058,672...29,061,844 		JBrowse link
G C22orf42 chromosome 22 open reading frame 42 decreases expression EXP clothianidin results in decreased expression of C22ORF42 mRNA CTD PMID:31626844 NCBI chr22:32,149,006...32,160,447
Ensembl chr22:32,149,006...32,159,322 		JBrowse link
G C2CD4B C2 calcium dependent domain containing 4B increases expression EXP clothianidin results in increased expression of C2CD4B mRNA CTD PMID:31626844 NCBI chr15:62,163,535...62,165,732
Ensembl chr15:62,163,535...62,165,285 		JBrowse link
G C4orf36 chromosome 4 open reading frame 36 decreases expression EXP clothianidin results in decreased expression of C4ORF36 mRNA CTD PMID:31626844 NCBI chr 4:86,876,205...86,897,256
Ensembl chr 4:86,876,205...86,892,422
Ensembl chr 4:86,876,205...86,892,422 		JBrowse link
G C5orf34 chromosome 5 open reading frame 34 increases expression EXP clothianidin results in increased expression of C5ORF34 mRNA CTD PMID:29044138 NCBI chr 5:43,486,699...43,515,433
Ensembl chr 5:43,486,709...43,515,148 		JBrowse link
G C5orf46 chromosome 5 open reading frame 46 increases expression EXP clothianidin results in increased expression of C5ORF46 mRNA CTD PMID:31626844 NCBI chr 5:147,850,463...147,906,594
Ensembl chr 5:147,880,726...147,906,538 		JBrowse link
G CA3 carbonic anhydrase 3 increases expression EXP clothianidin results in increased expression of CA3 mRNA CTD PMID:31626844 NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040 		JBrowse link
G CACNB2 calcium voltage-gated channel auxiliary subunit beta 2 decreases expression EXP clothianidin results in decreased expression of CACNB2 mRNA CTD PMID:31626844 NCBI chr10:18,140,424...18,545,881
Ensembl chr10:18,140,677...18,543,557
Ensembl chr10:18,140,677...18,543,557 		JBrowse link
G CALHM3 calcium homeostasis modulator 3 increases expression EXP clothianidin results in increased expression of CALHM3 mRNA CTD PMID:31626844 NCBI chr10:103,472,804...103,479,240
Ensembl chr10:103,472,804...103,479,240 		JBrowse link
G CAPN5 calpain 5 increases expression EXP clothianidin results in increased expression of CAPN5 mRNA CTD PMID:29044138 NCBI chr11:77,066,971...77,126,155
Ensembl chr11:77,066,961...77,126,155 		JBrowse link
G CAPS calcyphosine decreases expression EXP clothianidin results in decreased expression of CAPS mRNA CTD PMID:29044138 NCBI chr19:5,914,254...5,916,211
Ensembl chr19:5,912,339...5,916,211 		JBrowse link
G CARMIL1 capping protein regulator and myosin 1 linker 1 decreases expression EXP clothianidin results in decreased expression of LRRC16A mRNA CTD PMID:31626844 NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530 		JBrowse link
G CARMIL3 capping protein regulator and myosin 1 linker 3 increases expression EXP clothianidin results in increased expression of CARMIL3 mRNA CTD PMID:29044138 NCBI chr14:24,052,009...24,069,729
Ensembl chr14:24,052,009...24,069,729 		JBrowse link
G CCDC17 coiled-coil domain containing 17 decreases expression EXP clothianidin results in decreased expression of CCDC17 mRNA CTD PMID:29044138 NCBI chr 1:45,620,044...45,624,787
Ensembl chr 1:45,620,044...45,624,057 		JBrowse link
G CCDC8 coiled-coil domain containing 8 increases expression EXP clothianidin results in increased expression of CCDC8 mRNA CTD PMID:31626844 NCBI chr19:46,410,329...46,413,564
Ensembl chr19:46,410,329...46,413,564 		JBrowse link
G CCSER1 coiled-coil serine rich protein 1 decreases expression EXP clothianidin results in decreased expression of CCSER1 mRNA CTD PMID:31626844 NCBI chr 4:90,127,394...91,605,295
Ensembl chr 4:90,127,535...91,601,913 		JBrowse link
G CD226 CD226 molecule decreases expression EXP clothianidin results in decreased expression of CD226 mRNA CTD PMID:31626844 NCBI chr18:69,853,274...69,962,086
Ensembl chr18:69,831,158...69,961,803 		JBrowse link
G CD34 CD34 molecule increases expression EXP clothianidin results in increased expression of CD34 mRNA CTD PMID:31626844 NCBI chr 1:207,880,972...207,911,125
Ensembl chr 1:207,880,972...207,911,402 		JBrowse link
G CD74 CD74 molecule increases expression EXP clothianidin results in increased expression of CD74 mRNA CTD PMID:31626844 NCBI chr 5:150,400,041...150,412,936
Ensembl chr 5:150,400,041...150,412,929 		JBrowse link
G CD8B CD8b molecule increases expression EXP clothianidin results in increased expression of CD8B mRNA CTD PMID:31626844 NCBI chr 2:86,815,369...86,861,886
Ensembl chr 2:86,815,339...86,861,924 		JBrowse link
G CDH8 cadherin 8 decreases expression EXP clothianidin results in decreased expression of CDH8 mRNA CTD PMID:31626844 NCBI chr16:61,640,398...62,036,446
Ensembl chr16:61,647,242...62,037,035 		JBrowse link
G CDRT1 CMT1A duplicated region transcript 1 increases expression EXP clothianidin results in increased expression of CDRT1 mRNA CTD PMID:31626844 NCBI chr17:15,565,482...15,619,704
Ensembl chr17:15,565,483...15,619,512
Ensembl chr17:15,565,483...15,619,512 		JBrowse link
G CDRT15L2 CMT1A duplicated region transcript 15 like 2 increases expression EXP clothianidin results in increased expression of CDRT15L2 mRNA CTD PMID:31626844 NCBI chr17:20,579,724...20,580,911
Ensembl chr17:20,579,724...20,580,911 		JBrowse link
G CEACAM6 CEA cell adhesion molecule 6 increases expression EXP clothianidin results in increased expression of CEACAM6 mRNA CTD PMID:31626844 NCBI chr19:41,755,529...41,772,211
Ensembl chr19:41,750,977...41,772,211 		JBrowse link
G CEMIP cell migration inducing hyaluronidase 1 increases expression EXP clothianidin results in increased expression of CEMIP mRNA CTD PMID:31626844 NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776 		JBrowse link
G CES2 carboxylesterase 2 multiple interactions EXP [clothianidin co-treated with thiacloprid] results in increased expression of CES2 protein CTD PMID:32201337 NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096 		JBrowse link
G CFAP94 cilia and flagella associated protein 94 decreases expression EXP clothianidin results in decreased expression of CFAP94 mRNA CTD PMID:31626844 NCBI chr12:25,107,057...25,195,160
Ensembl chr12:25,108,289...25,195,162 		JBrowse link
G CHRNA4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions EXP clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] CTD PMID:21538459 NCBI chr20:63,343,223...63,375,471
Ensembl chr20:63,343,223...63,378,401 		JBrowse link
G CHRNB2 cholinergic receptor nicotinic beta 2 subunit multiple interactions ISO
EXP		 clothianidin results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]; clothianidin results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]
clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]		 CTD PMID:16981889 PMID:21538459 PMID:25459289 NCBI chr 1:154,567,778...154,584,708
Ensembl chr 1:154,567,778...154,580,013 		JBrowse link
G CHST3 carbohydrate sulfotransferase 3 increases expression EXP clothianidin results in increased expression of CHST3 mRNA CTD PMID:29044138 NCBI chr10:71,964,395...72,013,562
Ensembl chr10:71,964,395...72,013,558 		JBrowse link
G CLEC3B C-type lectin domain family 3 member B increases expression EXP clothianidin results in increased expression of CLEC3B mRNA CTD PMID:31626844 NCBI chr 3:45,026,207...45,036,071
Ensembl chr 3:45,001,548...45,036,071 		JBrowse link
G CMTM5 CKLF like MARVEL transmembrane domain containing 5 increases expression EXP clothianidin results in increased expression of CMTM5 mRNA CTD PMID:31626844 NCBI chr14:23,376,432...23,379,772
Ensembl chr14:23,376,773...23,379,772 		JBrowse link
G CNTNAP1 contactin associated protein 1 decreases expression EXP clothianidin results in decreased expression of CNTNAP1 mRNA CTD PMID:31626844 NCBI chr17:42,679,767...42,699,993
Ensembl chr17:42,682,531...42,699,993 		JBrowse link
G COL12A1 collagen type XII alpha 1 chain decreases expression EXP clothianidin results in decreased expression of COL12A1 mRNA CTD PMID:31626844 NCBI chr 6:75,084,326...75,206,262
Ensembl chr 6:75,084,326...75,206,053 		JBrowse link
G COL1A1 collagen type I alpha 1 chain decreases expression EXP clothianidin results in decreased expression of COL1A1 mRNA CTD PMID:29044138 NCBI chr17:50,184,096...50,201,649
Ensembl chr17:50,183,289...50,201,632
Ensembl chr17:50,183,289...50,201,632 		JBrowse link
G COL6A2 collagen type VI alpha 2 chain increases expression EXP clothianidin results in increased expression of COL6A2 mRNA CTD PMID:31626844 NCBI chr21:46,098,071...46,132,849
Ensembl chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848 		JBrowse link
G COL7A1 collagen type VII alpha 1 chain decreases expression EXP clothianidin results in decreased expression of COL7A1 mRNA CTD PMID:29044138 NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,267 		JBrowse link
G CORO2B coronin 2B decreases expression EXP clothianidin results in decreased expression of CORO2B mRNA CTD PMID:31626844 NCBI chr15:68,518,373...68,727,806
Ensembl chr15:68,578,993...68,727,806
Ensembl chr15:68,578,993...68,727,806 		JBrowse link
G CPEB3 cytoplasmic polyadenylation element binding protein 3 decreases expression EXP clothianidin results in decreased expression of CPEB3 mRNA CTD PMID:31626844 NCBI chr10:92,046,692...92,291,499
Ensembl chr10:92,046,692...92,291,078 		JBrowse link
G CPNE4 copine 4 increases expression EXP clothianidin results in increased expression of CPNE4 mRNA CTD PMID:31626844 NCBI chr 3:131,533,569...132,285,696
Ensembl chr 3:131,533,555...132,285,410 		JBrowse link
G CSMD1 CUB and Sushi multiple domains 1 increases expression EXP clothianidin results in increased expression of CSMD1 mRNA CTD PMID:31626844 NCBI chr 8:2,935,353...4,995,035
Ensembl chr 8:2,935,353...4,994,972 		JBrowse link
G CXADR CXADR Ig-like cell adhesion molecule increases expression EXP clothianidin results in increased expression of CXADR mRNA CTD PMID:29044138 NCBI chr21:17,513,016...17,636,213
Ensembl chr21:17,513,043...17,593,579 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases expression
multiple interactions		 EXP clothianidin results in increased expression of CYP1A2 mRNA
[clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA		 CTD PMID:32201337 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 multiple interactions EXP [clothianidin co-treated with enilconazole] results in increased expression of CYP1B1 protein CTD PMID:32201337 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902 		JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 multiple interactions EXP [clothianidin co-treated with enilconazole] results in decreased expression of CYP2A6 protein; [clothianidin co-treated with thiacloprid] results in increased expression of CYP2A6 protein CTD PMID:32201337 NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447 		JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions EXP [clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein CTD PMID:32201337 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398 		JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 multiple interactions EXP [clothianidin co-treated with thiacloprid] results in increased expression of CYP2C9 protein CTD PMID:32201337 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 multiple interactions
decreases expression		 EXP [clothianidin co-treated with enilconazole] results in decreased expression of CYP2E1 mRNA; [clothianidin co-treated with thiacloprid] results in increased expression of CYP2E1 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA
clothianidin results in decreased expression of CYP2E1 mRNA		 CTD PMID:32201337 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions
increases expression		 EXP [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 mRNA; [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 protein; [clothianidin co-treated with thiacloprid] results in increased expression of CYP3A4 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP3A4 mRNA
clothianidin results in increased expression of CYP3A4 mRNA		 CTD PMID:32201337 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 increases expression
multiple interactions		 EXP clothianidin results in increased expression of CYP3A5 mRNA
[clothianidin co-treated with enilconazole] results in increased expression of CYP3A5 protein; [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A5 mRNA		 CTD PMID:32201337 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,998 		JBrowse link
G CYTH4 cytohesin 4 increases expression EXP clothianidin results in increased expression of CYTH4 mRNA CTD PMID:31626844 NCBI chr22:37,282,508...37,315,341
Ensembl chr22:37,282,027...37,315,341 		JBrowse link
G DACT1 dishevelled binding antagonist of beta catenin 1 decreases expression EXP clothianidin results in decreased expression of DACT1 mRNA CTD PMID:31626844 NCBI chr14:58,634,061...58,648,321
Ensembl chr14:58,633,967...58,648,321 		JBrowse link
G DEFA5 defensin alpha 5 decreases expression EXP clothianidin results in decreased expression of DEFA5 mRNA CTD PMID:31626844 NCBI chr 8:7,055,304...7,056,739
Ensembl chr 8:7,055,304...7,056,739 		JBrowse link
G DES desmin increases expression EXP clothianidin results in increased expression of DES mRNA CTD PMID:31626844 NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,734 		JBrowse link
G DGKD diacylglycerol kinase delta increases expression EXP clothianidin results in increased expression of DGKD mRNA CTD PMID:31626844 NCBI chr 2:233,354,494...233,472,098
Ensembl chr 2:233,354,494...233,472,104
Ensembl chr 2:233,354,494...233,472,104 		JBrowse link
G DIO3 iodothyronine deiodinase 3 increases expression EXP clothianidin results in increased expression of DIO3 mRNA CTD PMID:31626844 NCBI chr14:101,561,351...101,563,452
Ensembl chr14:101,561,351...101,563,452 		JBrowse link
G DLL3 delta like canonical Notch ligand 3 decreases expression EXP clothianidin results in decreased expression of DLL3 mRNA CTD PMID:31626844 NCBI chr19:39,498,947...39,508,469
Ensembl chr19:39,498,895...39,508,481 		JBrowse link
G DNAJC21 DnaJ heat shock protein family (Hsp40) member C21 increases expression EXP clothianidin results in increased expression of DNAJC21 mRNA CTD PMID:31626844 NCBI chr 5:34,929,540...34,958,964
Ensembl chr 5:34,929,559...34,958,964 		JBrowse link
G DNAJC28 DnaJ heat shock protein family (Hsp40) member C28 decreases expression EXP clothianidin results in decreased expression of DNAJC28 mRNA CTD PMID:31626844 NCBI chr21:33,488,055...33,491,716
Ensembl chr21:33,485,530...33,491,716
Ensembl chr21:33,485,530...33,491,716 		JBrowse link
G DNAJC5G DnaJ heat shock protein family (Hsp40) member C5 gamma increases expression EXP clothianidin results in increased expression of DNAJC5G mRNA CTD PMID:31626844 NCBI chr 2:27,275,427...27,281,499
Ensembl chr 2:27,275,433...27,281,499 		JBrowse link
G DNASE1L2 deoxyribonuclease 1 like 2 decreases expression EXP clothianidin results in decreased expression of DNASE1L2 mRNA CTD PMID:29044138 NCBI chr16:2,236,444...2,238,711
Ensembl chr16:2,235,816...2,238,711 		JBrowse link
G DNHD1 dynein heavy chain domain 1 decreases expression EXP clothianidin results in decreased expression of DNHD1 mRNA CTD PMID:29044138 NCBI chr11:6,497,280...6,572,020
Ensembl chr11:6,497,260...6,593,758 		JBrowse link
G DOK5 docking protein 5 decreases expression EXP clothianidin results in decreased expression of DOK5 mRNA CTD PMID:31626844 NCBI chr20:54,475,593...54,651,171
Ensembl chr20:54,475,593...54,651,169 		JBrowse link
G DUS3L dihydrouridine synthase 3 like increases expression EXP clothianidin results in increased expression of DUS3L mRNA CTD PMID:31626844 NCBI chr19:5,785,136...5,791,210
Ensembl chr19:5,784,832...5,791,225 		JBrowse link
G DUSP15 dual specificity phosphatase 15 increases expression EXP clothianidin results in increased expression of DUSP15 mRNA CTD PMID:29044138 NCBI chr20:31,845,578...31,870,664
Ensembl chr20:31,847,637...31,870,747 		JBrowse link
G DUSP16 dual specificity phosphatase 16 decreases expression EXP clothianidin results in decreased expression of DUSP16 mRNA CTD PMID:31626844 NCBI chr12:12,473,282...12,562,863
Ensembl chr12:12,473,282...12,562,863 		JBrowse link
G EAF2 ELL associated factor 2 decreases expression EXP clothianidin results in decreased expression of EAF2 mRNA CTD PMID:31626844 NCBI chr 3:121,835,180...121,886,526
Ensembl chr 3:121,835,183...121,886,526 		JBrowse link
G ECE2 endothelin converting enzyme 2 increases expression EXP clothianidin results in increased expression of ECE2 mRNA CTD PMID:31626844 NCBI chr 3:184,276,022...184,293,031
Ensembl chr 3:184,276,011...184,293,031 		JBrowse link
G EFCAB12 EF-hand calcium binding domain 12 decreases expression EXP clothianidin results in decreased expression of EFCAB12 mRNA CTD PMID:29044138 NCBI chr 3:129,401,321...129,428,636
Ensembl chr 3:129,401,321...129,428,651 		JBrowse link
G EFS embryonal Fyn-associated substrate decreases expression EXP clothianidin results in decreased expression of EFS mRNA CTD PMID:31626844 NCBI chr14:23,356,402...23,365,207
Ensembl chr14:23,356,403...23,365,752 		JBrowse link
G EIF3F eukaryotic translation initiation factor 3 subunit F decreases expression EXP clothianidin results in decreased expression of EIF3F mRNA CTD PMID:31626844 NCBI chr11:7,987,337...8,001,852
Ensembl chr11:7,970,251...8,001,862 		JBrowse link
G ELF1 E74 like ETS transcription factor 1 increases expression EXP clothianidin results in increased expression of ELF1 mRNA CTD PMID:31626844 NCBI chr13:40,931,919...41,061,386
Ensembl chr13:40,931,924...41,061,440 		JBrowse link
G ELMOD1 ELMO domain containing 1 decreases expression EXP clothianidin results in decreased expression of ELMOD1 mRNA CTD PMID:31626844 NCBI chr11:107,591,009...107,666,779
Ensembl chr11:107,591,091...107,666,779 		JBrowse link
G ENPP4 ectonucleotide pyrophosphatase/phosphodiesterase 4 increases expression EXP clothianidin results in increased expression of ENPP4 mRNA CTD PMID:29044138 NCBI chr 6:46,129,989...46,146,688
Ensembl chr 6:46,129,989...46,146,688 		JBrowse link
G EPDR1 ependymin related 1 increases expression EXP clothianidin results in increased expression of EPDR1 mRNA CTD PMID:29044138 NCBI chr 7:37,920,640...37,951,936
Ensembl chr 7:37,683,843...37,951,936 		JBrowse link
G EPN3 epsin 3 decreases expression EXP clothianidin results in decreased expression of EPN3 mRNA CTD PMID:31626844 NCBI chr17:50,532,735...50,543,750
Ensembl chr17:50,532,682...50,543,750 		JBrowse link
G EPS8 epidermal growth factor receptor pathway substrate 8 increases expression EXP clothianidin results in increased expression of EPS8 mRNA CTD PMID:29044138 NCBI chr12:15,620,134...15,789,388
Ensembl chr12:15,620,134...15,882,329 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 increases expression EXP clothianidin results in increased expression of ERBB3 mRNA CTD PMID:31626844 NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505 		JBrowse link
G ERGIC1 endoplasmic reticulum-golgi intermediate compartment 1 increases expression EXP clothianidin results in increased expression of ERGIC1 mRNA CTD PMID:31626844 NCBI chr 5:172,834,251...172,952,683
Ensembl chr 5:172,834,251...172,952,683 		JBrowse link
G EXOC4 exocyst complex component 4 decreases expression EXP clothianidin results in decreased expression of EXOC4 mRNA CTD PMID:31626844 NCBI chr 7:133,253,075...134,067,137
Ensembl chr 7:133,253,073...134,066,589 		JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression EXP clothianidin results in decreased expression of EZH2 mRNA CTD PMID:31626844 NCBI chr 7:148,807,374...148,884,344
Ensembl chr 7:148,807,383...148,884,321 		JBrowse link
G F2 coagulation factor II, thrombin decreases expression EXP clothianidin results in decreased expression of F2 mRNA CTD PMID:31626844 NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
Ensembl chr11:46,719,196...46,739,506 		JBrowse link
G FAM110C family with sequence similarity 110 member C increases expression EXP clothianidin results in increased expression of FAM110C mRNA CTD PMID:31626844 NCBI chr 2:38,814...47,077
Ensembl chr 2:38,814...46,870 		JBrowse link
G FAM131A family with sequence similarity 131 member A decreases expression EXP clothianidin results in decreased expression of FAM131A mRNA CTD PMID:31626844 NCBI chr 3:184,335,924...184,346,275
Ensembl chr 3:184,335,926...184,348,421 		JBrowse link
G FAM151B family with sequence similarity 151 member B decreases expression EXP clothianidin results in decreased expression of FAM151B mRNA CTD PMID:31626844 NCBI chr 5:80,488,069...80,542,563
Ensembl chr 5:80,487,969...80,542,563 		JBrowse link
G FAM162B family with sequence similarity 162 member B increases expression EXP clothianidin results in increased expression of FAM162B mRNA CTD PMID:31626844 NCBI chr 6:116,752,197...116,765,719
Ensembl chr 6:116,752,197...116,765,719 		JBrowse link
G FAM169A family with sequence similarity 169 member A increases expression EXP clothianidin results in increased expression of FAM169A mRNA CTD PMID:29044138 NCBI chr 5:74,777,574...74,867,994
Ensembl chr 5:74,777,574...74,866,966 		JBrowse link
G FAM229A family with sequence similarity 229 member A decreases expression EXP clothianidin results in decreased expression of FAM229A mRNA CTD PMID:29044138 NCBI chr 1:32,361,270...32,362,243
Ensembl chr 1:32,361,270...32,364,278 		JBrowse link
G FAM243A family with sequence similarity 243 member A increases expression EXP clothianidin results in increased expression of C21ORF140 mRNA CTD PMID:31626844 NCBI chr21:34,400,112...34,401,072
Ensembl chr21:34,400,112...34,401,072 		JBrowse link
G FAM47B family with sequence similarity 47 member B increases expression EXP clothianidin results in increased expression of FAM47B mRNA CTD PMID:31626844 NCBI chr  X:34,942,796...34,944,915
Ensembl chr  X:34,942,796...34,944,915 		JBrowse link
G FAR2P1 fatty acyl-CoA reductase 2 pseudogene 1 decreases expression EXP clothianidin results in decreased expression of FAR2P1 mRNA CTD PMID:31626844 NCBI chr 2:130,025,998...130,051,131
Ensembl chr 2:130,012,065...130,040,560
Ensembl chr 2:130,012,065...130,040,560 		JBrowse link
G FBXL19-AS1 FBXL19 antisense RNA 1 decreases expression EXP clothianidin results in decreased expression of FBXL19-AS1 mRNA CTD PMID:29044138 NCBI chr16:30,919,319...30,923,269
Ensembl chr16:30,919,319...30,923,269 		JBrowse link
G FBXO33 F-box protein 33 decreases expression EXP clothianidin results in decreased expression of FBXO33 mRNA CTD PMID:31626844 NCBI chr14:39,396,373...39,432,500
Ensembl chr14:39,397,669...39,432,500 		JBrowse link
G FCN3 ficolin 3 increases expression EXP clothianidin results in increased expression of FCN3 mRNA CTD PMID:31626844 NCBI chr 1:27,369,110...27,374,852
Ensembl chr 1:27,369,110...27,374,824
Ensembl chr 1:27,369,110...27,374,824 		JBrowse link
G FER1L4 fer-1 like family member 4 (pseudogene) decreases expression EXP clothianidin results in decreased expression of FER1L4 mRNA CTD PMID:29044138 NCBI chr20:35,558,737...35,607,562
Ensembl chr20:35,558,737...35,607,562 		JBrowse link
G FILIP1 filamin A interacting protein 1 increases expression EXP clothianidin results in increased expression of FILIP1 mRNA CTD PMID:31626844 NCBI chr 6:75,291,858...75,493,800
Ensembl chr 6:75,291,859...75,493,800 		JBrowse link
G FITM1 fat storage inducing transmembrane protein 1 increases expression EXP clothianidin results in increased expression of FITM1 mRNA CTD PMID:31626844 NCBI chr14:24,130,659...24,132,847
Ensembl chr14:24,131,275...24,132,849 		JBrowse link
G FOLR2 folate receptor beta increases expression EXP clothianidin results in increased expression of FOLR2 mRNA CTD PMID:31626844 NCBI chr11:72,216,794...72,221,950
Ensembl chr11:72,216,601...72,221,950 		JBrowse link
G FOXO1 forkhead box O1 increases expression EXP clothianidin results in increased expression of FOXO1 mRNA CTD PMID:31626844 NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641 		JBrowse link
G FOXO4 forkhead box O4 decreases expression EXP clothianidin results in decreased expression of FOXO4 mRNA CTD PMID:29044138 NCBI chr  X:71,095,851...71,103,534
Ensembl chr  X:71,095,851...71,103,532 		JBrowse link
G FTCDNL1 formiminotransferase cyclodeaminase N-terminal like increases expression EXP clothianidin results in increased expression of FTCDNL1 mRNA CTD PMID:29044138 NCBI chr 2:199,663,332...199,851,192
Ensembl chr 2:199,760,544...199,851,173
Ensembl chr 2:199,760,544...199,851,173 		JBrowse link
G FYB1 FYN binding protein 1 decreases expression EXP clothianidin results in decreased expression of FYB mRNA CTD PMID:31626844 NCBI chr 5:39,105,252...39,274,500
Ensembl chr 5:39,105,252...39,274,528 		JBrowse link
G GAGE10 G antigen 10 increases expression EXP clothianidin results in increased expression of GAGE10 mRNA CTD PMID:31626844 NCBI chr  X:49,303,646...49,319,844
Ensembl chr  X:49,303,669...49,319,844 		JBrowse link
G GASK1A golgi associated kinase 1A increases expression EXP clothianidin results in increased expression of FAM198A mRNA CTD PMID:31626844 NCBI chr 3:42,979,311...43,057,715
Ensembl chr 3:42,979,267...43,060,211 		JBrowse link
G GHRHR growth hormone releasing hormone receptor increases expression EXP clothianidin results in increased expression of GHRHR mRNA CTD PMID:31626844 NCBI chr 7:30,963,953...30,979,528
Ensembl chr 7:30,938,669...30,993,254 		JBrowse link
G GLI1 GLI family zinc finger 1 decreases expression EXP clothianidin results in decreased expression of GLI1 mRNA CTD PMID:31626844 NCBI chr12:57,459,785...57,472,451
Ensembl chr12:57,459,785...57,472,268 		JBrowse link
G GNGT1 G protein subunit gamma transducin 1 decreases expression EXP clothianidin results in decreased expression of GNGT1 mRNA CTD PMID:31626844 NCBI chr 7:93,906,567...93,911,265
Ensembl chr 7:93,591,573...93,911,265 		JBrowse link
G GPC6 glypican 6 increases expression EXP clothianidin results in increased expression of GPC6 mRNA CTD PMID:31626844 NCBI chr13:93,226,807...94,408,020
Ensembl chr13:93,226,807...94,408,020 		JBrowse link
G GPCPD1 glycerophosphocholine phosphodiesterase 1 increases expression EXP clothianidin results in increased expression of GPCPD1 mRNA CTD PMID:31626844 NCBI chr20:5,544,439...5,611,046
Ensembl chr20:5,544,439...5,611,006
Ensembl chr20:5,544,439...5,611,006 		JBrowse link
G GPIHBP1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 increases expression EXP clothianidin results in increased expression of GPIHBP1 mRNA CTD PMID:31626844 NCBI chr 8:143,213,218...143,217,170
Ensembl chr 8:143,213,218...143,217,170 		JBrowse link
G GPX4 glutathione peroxidase 4 decreases expression ISO clothianidin results in decreased expression of GPX4 protein CTD PMID:25960033 NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,926...1,106,791 		JBrowse link
G GRAMD1C GRAM domain containing 1C decreases expression EXP clothianidin results in decreased expression of GRAMD1C mRNA CTD PMID:31626844 NCBI chr 3:113,828,182...113,947,174
Ensembl chr 3:113,828,182...113,947,174 		JBrowse link
G GRAMD2A GRAM domain containing 2A decreases expression EXP clothianidin results in decreased expression of GRAMD2 mRNA CTD PMID:31626844 NCBI chr15:72,159,806...72,197,814
Ensembl chr15:72,159,806...72,197,787 		JBrowse link
G GSKIP GSK3B interacting protein increases expression EXP clothianidin results in increased expression of GSKIP mRNA CTD PMID:29044138 NCBI chr14:96,363,526...96,387,290
Ensembl chr14:96,363,452...96,387,288 		JBrowse link
G GTF3C5 general transcription factor IIIC subunit 5 increases expression EXP clothianidin results in increased expression of GTF3C5 mRNA CTD PMID:31626844 NCBI chr 9:133,030,689...133,058,503
Ensembl chr 9:133,030,675...133,058,503 		JBrowse link
G GTSF1L gametocyte specific factor 1 like increases expression EXP clothianidin results in increased expression of GTSF1L mRNA CTD PMID:31626844 NCBI chr20:43,726,161...43,727,135
Ensembl chr20:43,726,164...43,727,002 		JBrowse link
G GYPC glycophorin C (Gerbich blood group) increases expression EXP clothianidin results in increased expression of GYPC mRNA CTD PMID:31626844 NCBI chr 2:126,656,158...126,696,668
Ensembl chr 2:126,656,133...126,696,667 		JBrowse link
G H1-7 H1.7 linker histone increases expression EXP clothianidin results in increased expression of H1-7 mRNA CTD PMID:31626844 NCBI chr12:48,328,980...48,330,279
Ensembl chr12:48,328,980...48,330,279 		JBrowse link
G HACD2 3-hydroxyacyl-CoA dehydratase 2 increases expression EXP clothianidin results in increased expression of HACD2 mRNA CTD PMID:29044138 NCBI chr 3:123,491,548...123,585,099
Ensembl chr 3:123,490,820...123,585,053 		JBrowse link
G HCK HCK proto-oncogene, Src family tyrosine kinase increases expression EXP clothianidin results in increased expression of HCK mRNA CTD PMID:31626844 NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
Ensembl chr20:32,052,197...32,101,856 		JBrowse link
G HECTD2 HECT domain E3 ubiquitin protein ligase 2 increases expression EXP clothianidin results in increased expression of HECTD2 mRNA CTD PMID:29044138 NCBI chr10:91,409,235...91,514,820
Ensembl chr10:91,409,280...91,514,829 		JBrowse link
G HECW2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 decreases expression EXP clothianidin results in decreased expression of HECW2 mRNA CTD PMID:31626844 NCBI chr 2:196,194,072...196,593,692
Ensembl chr 2:196,189,099...196,593,684 		JBrowse link
G HGF hepatocyte growth factor decreases expression EXP clothianidin results in decreased expression of HGF mRNA CTD PMID:31626844 NCBI chr 7:81,699,006...81,770,438
Ensembl chr 7:81,699,010...81,770,438 		JBrowse link
G HID1 HID1 domain containing decreases expression EXP clothianidin results in decreased expression of HID1 mRNA CTD PMID:31626844 NCBI chr17:74,950,742...74,972,763
Ensembl chr17:74,950,742...74,973,166 		JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 increases expression EXP clothianidin results in increased expression of HLA-DQB1 mRNA CTD PMID:31626844 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383 		JBrowse link
G HMBS hydroxymethylbilane synthase increases expression EXP clothianidin results in increased expression of HMBS mRNA CTD PMID:31626844 NCBI chr11:119,084,864...119,093,549
Ensembl chr11:119,084,866...119,093,549 		JBrowse link
G HNF1B HNF1 homeobox B increases expression EXP clothianidin results in increased expression of HNF1B mRNA CTD PMID:31626844 NCBI chr17:37,686,431...37,745,059
Ensembl chr17:37,686,431...37,745,105 		JBrowse link
G HNF4A hepatocyte nuclear factor 4 alpha increases expression EXP clothianidin results in increased expression of HNF4A mRNA CTD PMID:31626844 NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,700...44,434,596 		JBrowse link
G HNRNPK heterogeneous nuclear ribonucleoprotein K decreases expression EXP clothianidin results in decreased expression of HNRNPK mRNA CTD PMID:31626844 NCBI chr 9:83,968,083...83,980,630
Ensembl chr 9:83,968,083...83,980,616 		JBrowse link
G IL17RE interleukin 17 receptor E decreases expression EXP clothianidin results in decreased expression of IL17RE mRNA CTD PMID:29044138 NCBI chr 3:9,902,087...9,916,402
Ensembl chr 3:9,902,612...9,916,402 		JBrowse link
G IL18BP interleukin 18 binding protein decreases expression EXP clothianidin results in decreased expression of IL18BP mRNA CTD PMID:29044138 NCBI chr11:71,997,944...72,002,919
Ensembl chr11:71,998,613...72,005,715 		JBrowse link
G IL2RG interleukin 2 receptor subunit gamma increases expression EXP clothianidin results in increased expression of IL2RG mRNA CTD PMID:31626844 NCBI chr  X:71,107,404...71,111,577
Ensembl chr  X:71,107,404...71,112,108 		JBrowse link
G IMMP1L inner mitochondrial membrane peptidase subunit 1 increases expression EXP clothianidin results in increased expression of IMMP1L mRNA CTD PMID:31626844 NCBI chr11:31,432,401...31,509,644
Ensembl chr11:31,432,401...31,509,645 		JBrowse link
G INSYN2B inhibitory synaptic factor family member 2B decreases expression EXP clothianidin results in decreased expression of FAM196B mRNA CTD PMID:31626844 NCBI chr 5:169,861,303...169,980,508
Ensembl chr 5:169,861,303...169,980,495 		JBrowse link
G IRX5 iroquois homeobox 5 decreases expression EXP clothianidin results in decreased expression of IRX5 mRNA CTD PMID:31626844 NCBI chr16:54,930,865...54,934,485
Ensembl chr16:54,930,865...54,934,485 		JBrowse link
G ITSN1 intersectin 1 decreases expression EXP clothianidin results in decreased expression of ITSN1 mRNA CTD PMID:31626844 NCBI chr21:33,642,452...33,899,861
Ensembl chr21:33,642,400...33,899,861 		JBrowse link
G JAK2 Janus kinase 2 decreases expression EXP clothianidin results in decreased expression of JAK2 mRNA CTD PMID:31626844 NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,128,183
Ensembl chr 9:4,984,390...5,128,183 		JBrowse link
G KAT6B lysine acetyltransferase 6B decreases expression EXP clothianidin results in decreased expression of KAT6B mRNA CTD PMID:31626844 NCBI chr10:74,824,927...75,032,624
Ensembl chr10:74,824,927...75,032,624 		JBrowse link
G KCNC4 potassium voltage-gated channel subfamily C member 4 increases expression EXP clothianidin results in increased expression of KCNC4 mRNA CTD PMID:31626844 NCBI chr 1:110,210,314...110,282,649
Ensembl chr 1:110,210,314...110,283,100
Ensembl chr 1:110,210,314...110,283,100 		JBrowse link
G KCND3 potassium voltage-gated channel subfamily D member 3 decreases expression EXP clothianidin results in decreased expression of KCND3 mRNA CTD PMID:31626844 NCBI chr 1:111,770,662...111,989,668
Ensembl chr 1:111,770,662...111,989,155
Ensembl chr 1:111,770,662...111,989,155 		JBrowse link
G KCNK1 potassium two pore domain channel subfamily K member 1 decreases expression EXP clothianidin results in decreased expression of KCNK1 mRNA CTD PMID:31626844 NCBI chr 1:233,614,106...233,672,514
Ensembl chr 1:233,614,106...233,672,514 		JBrowse link
G KCNMA1 potassium calcium-activated channel subfamily M alpha 1 decreases expression EXP clothianidin results in decreased expression of KCNMA1 mRNA CTD PMID:31626844 NCBI chr10:76,869,602...77,637,969
Ensembl chr10:76,869,601...77,638,369 		JBrowse link
G KIF7 kinesin family member 7 increases expression EXP clothianidin results in increased expression of KIF7 mRNA CTD PMID:31626844 NCBI chr15:89,627,977...89,663,086
Ensembl chr15:89,608,789...89,655,467 		JBrowse link
G KIFC3 kinesin family member C3 increases expression EXP clothianidin results in increased expression of KIFC3 mRNA CTD PMID:31626844 NCBI chr16:57,758,217...57,863,053
Ensembl chr16:57,758,217...57,863,053 		JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase increases expression EXP clothianidin results in increased expression of KIT mRNA CTD PMID:31626844 NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,918...54,740,715 		JBrowse link
G KLHDC9 kelch domain containing 9 decreases expression EXP clothianidin results in decreased expression of KLHDC9 mRNA CTD PMID:31626844 NCBI chr 1:161,098,361...161,100,346
Ensembl chr 1:161,098,361...161,100,346 		JBrowse link
G KPNA6 karyopherin subunit alpha 6 increases expression EXP clothianidin results in increased expression of KPNA6 mRNA CTD PMID:31626844 NCBI chr 1:32,108,043...32,176,563
Ensembl chr 1:32,108,056...32,176,563 		JBrowse link
G KRT28 keratin 28 increases expression EXP clothianidin results in increased expression of KRT28 mRNA CTD PMID:31626844 NCBI chr17:40,792,196...40,799,959
Ensembl chr17:40,792,196...40,799,959 		JBrowse link
G KRTAP19-5 keratin associated protein 19-5 increases expression EXP clothianidin results in increased expression of KRTAP19-5 mRNA CTD PMID:31626844 NCBI chr21:30,501,657...30,502,141
Ensembl chr21:30,501,657...30,502,141 		JBrowse link
G KRTAP9-8 keratin associated protein 9-8 increases expression EXP clothianidin results in increased expression of KRTAP9-8 mRNA CTD PMID:31626844 NCBI chr17:41,237,999...41,239,004
Ensembl chr17:41,237,999...41,239,004 		JBrowse link
G KSR1 kinase suppressor of ras 1 decreases expression EXP clothianidin results in decreased expression of KSR1 mRNA CTD PMID:31626844 NCBI chr17:27,456,441...27,626,438
Ensembl chr17:27,456,470...27,626,438 		JBrowse link
G L3MBTL1 L3MBTL histone methyl-lysine binding protein 1 decreases expression EXP clothianidin results in decreased expression of L3MBTL1 mRNA CTD PMID:31626844 NCBI chr20:43,507,697...43,550,954
Ensembl chr20:43,489,442...43,550,954
Ensembl chr20:43,489,442...43,550,954 		JBrowse link
G LCNL1 lipocalin like 1 decreases expression EXP clothianidin results in decreased expression of LCNL1 mRNA CTD PMID:29044138 NCBI chr 9:136,982,993...136,985,758
Ensembl chr 9:136,981,904...136,986,410 		JBrowse link
G LGALS12 galectin 12 increases expression EXP clothianidin results in increased expression of LGALS12 mRNA CTD PMID:31626844 NCBI chr11:63,506,052...63,516,772
Ensembl chr11:63,506,084...63,516,774
Ensembl chr11:63,506,084...63,516,774 		JBrowse link
G LGI4 leucine rich repeat LGI family member 4 increases expression EXP clothianidin results in increased expression of LGI4 mRNA CTD PMID:31626844 NCBI chr19:35,124,513...35,135,059
Ensembl chr19:35,124,513...35,142,451 		JBrowse link
G LIM2 lens intrinsic membrane protein 2 increases expression EXP clothianidin results in increased expression of LIM2 mRNA CTD PMID:31626844 NCBI chr19:51,379,909...51,387,974
Ensembl chr19:51,379,909...51,387,960
Ensembl chr19:51,379,909...51,387,960 		JBrowse link
G LINC00272 long intergenic non-protein coding RNA 272 increases expression EXP clothianidin results in increased expression of LINC00272 mRNA CTD PMID:31626844 NCBI chr 1:182,407,621...182,414,813
Ensembl chr 1:182,407,621...182,414,815 		JBrowse link
G LINC00649 long intergenic non-protein coding RNA 649 decreases expression EXP clothianidin results in decreased expression of LINC00649 mRNA CTD PMID:31626844 NCBI chr21:33,931,122...33,971,186
Ensembl chr21:33,915,534...33,977,691 		JBrowse link
G LINC01465 long intergenic non-protein coding RNA 1465 increases expression EXP clothianidin results in increased expression of LINC01465 mRNA CTD PMID:31626844 NCBI chr12:62,601,751...62,603,434
Ensembl chr12:62,601,751...62,603,690 		JBrowse link
G LONRF1 LON peptidase N-terminal domain and ring finger 1 increases expression EXP clothianidin results in increased expression of LONRF1 mRNA CTD PMID:31626844 NCBI chr 8:12,721,900...12,755,526
Ensembl chr 8:12,721,906...12,756,073 		JBrowse link
G LOX lysyl oxidase increases expression EXP clothianidin results in increased expression of LOX mRNA CTD PMID:29044138 NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,360
Ensembl chr 5:122,063,195...122,078,360 		JBrowse link
G LPAR1 lysophosphatidic acid receptor 1 decreases expression EXP clothianidin results in decreased expression of LPAR1 mRNA CTD PMID:31626844 NCBI chr 9:110,873,252...111,038,998
Ensembl chr 9:110,873,263...111,038,458 		JBrowse link
G LRIG1 leucine rich repeats and immunoglobulin like domains 1 increases expression EXP clothianidin results in increased expression of LRIG1 mRNA CTD PMID:31626844 NCBI chr 3:66,378,797...66,501,121
Ensembl chr 3:66,378,797...66,501,263 		JBrowse link
G LRRC74B leucine rich repeat containing 74B decreases expression EXP clothianidin results in decreased expression of LRRC74B mRNA CTD PMID:31626844 NCBI chr22:21,045,946...21,064,168
Ensembl chr22:21,045,960...21,064,168 		JBrowse link
G LUZP2 leucine zipper protein 2 increases expression EXP clothianidin results in increased expression of LUZP2 mRNA CTD PMID:31626844 NCBI chr11:24,496,488...25,082,638
Ensembl chr11:24,496,970...25,082,638 		JBrowse link
G LYSMD2 LysM domain containing 2 decreases expression EXP clothianidin results in decreased expression of LYSMD2 mRNA CTD PMID:31626844 NCBI chr15:51,723,011...51,751,451
Ensembl chr15:51,723,011...51,751,585 		JBrowse link
G MAP1LC3C microtubule associated protein 1 light chain 3 gamma increases expression EXP clothianidin results in increased expression of MAP1LC3C mRNA CTD PMID:31626844 NCBI chr 1:241,995,194...242,001,393
Ensembl chr 1:241,995,490...241,999,098 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation EXP clothianidin results in increased phosphorylation of MAPK1 protein CTD PMID:31626844 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,754,500...21,867,680
Ensembl chr22:21,754,500...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation EXP clothianidin results in increased phosphorylation of MAPK3 protein CTD PMID:31626844 NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MCHR1 melanin concentrating hormone receptor 1 increases expression EXP clothianidin results in increased expression of MCHR1 mRNA CTD PMID:31626844 NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,678,750...40,682,814 		JBrowse link
G MEIOC meiosis specific with coiled-coil domain increases expression EXP clothianidin results in increased expression of MEIOC mRNA CTD PMID:31626844 NCBI chr17:44,656,417...44,677,086
Ensembl chr17:44,656,404...44,690,308 		JBrowse link
G METTL16 methyltransferase like 16 increases expression EXP clothianidin results in increased expression of METTL16 mRNA CTD PMID:31626844 NCBI chr17:2,416,049...2,511,901
Ensembl chr17:2,405,562...2,511,891 		JBrowse link
G METTL7A methyltransferase like 7A decreases expression EXP clothianidin results in decreased expression of METTL7A mRNA CTD PMID:29044138 NCBI chr12:50,925,015...50,932,508
Ensembl chr12:50,923,472...50,932,510 		JBrowse link
G MICAL1 microtubule associated monooxygenase, calponin and LIM domain containing 1 increases expression EXP clothianidin results in increased expression of MICAL1 mRNA CTD PMID:31626844 NCBI chr 6:109,444,062...109,465,968
Ensembl chr 6:109,444,062...109,465,968 		JBrowse link
G MICALL2 MICAL like 2 decreases expression EXP clothianidin results in decreased expression of MICALL2 mRNA CTD PMID:29044138 NCBI chr 7:1,433,639...1,459,497
Ensembl chr 7:1,428,465...1,459,470 		JBrowse link
G MLANA melan-A increases expression EXP clothianidin results in increased expression of MLANA mRNA CTD PMID:31626844 NCBI chr 9:5,890,889...5,910,606
Ensembl chr 9:5,890,889...5,910,606 		JBrowse link
G MMP10 matrix metallopeptidase 10 increases expression EXP clothianidin results in increased expression of MMP10 mRNA CTD PMID:31626844 NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628 		JBrowse link
G MS4A2 membrane spanning 4-domains A2 decreases expression EXP clothianidin results in decreased expression of MS4A2 mRNA CTD PMID:29044138 NCBI chr11:60,088,261...60,098,467
Ensembl chr11:60,088,261...60,098,467 		JBrowse link
G MSS51 MSS51 mitochondrial translational activator decreases expression EXP clothianidin results in decreased expression of MSS51 mRNA CTD PMID:29044138 NCBI chr10:73,423,579...73,433,561
Ensembl chr10:73,423,579...73,433,561 		JBrowse link
G MTG1 mitochondrial ribosome associated GTPase 1 decreases expression EXP clothianidin results in decreased expression of MTG1 mRNA CTD PMID:29044138 NCBI chr10:133,394,157...133,422,520
Ensembl chr10:133,394,094...133,422,520 		JBrowse link
G MUC22 mucin 22 increases expression EXP clothianidin results in increased expression of MUC22 mRNA CTD PMID:31626844 NCBI chr 6:31,005,952...31,035,402
Ensembl chr 6:31,010,474...31,035,402 		JBrowse link
G MYL4 myosin light chain 4 decreases expression EXP clothianidin results in decreased expression of MYL4 mRNA CTD PMID:31626844 NCBI chr17:47,209,017...47,227,650
Ensembl chr17:47,200,446...47,223,679 		JBrowse link
G MYL6 myosin light chain 6 decreases expression EXP clothianidin results in decreased expression of MYL6 mRNA CTD PMID:31626844 NCBI chr12:56,158,359...56,161,579
Ensembl chr12:56,158,161...56,163,496
Ensembl chr12:56,158,161...56,163,496 		JBrowse link
G MYLPF myosin light chain, phosphorylatable, fast skeletal muscle decreases expression EXP clothianidin results in decreased expression of MYLPF mRNA CTD PMID:31626844 NCBI chr16:30,370,934...30,377,991
Ensembl chr16:30,370,934...30,377,991 		JBrowse link
G MYO3B myosin IIIB increases expression EXP clothianidin results in increased expression of MYO3B mRNA CTD PMID:31626844 NCBI chr 2:170,178,147...170,655,167
Ensembl chr 2:170,178,145...170,655,171 		JBrowse link
G MYORG myogenesis regulating glycosidase (putative) increases expression EXP clothianidin results in increased expression of MYORG mRNA CTD PMID:29044138 NCBI chr 9:34,366,149...34,376,952
Ensembl chr 9:34,366,666...34,376,898 		JBrowse link
G MYT1L myelin transcription factor 1 like increases expression EXP clothianidin results in increased expression of MYT1L mRNA CTD PMID:31626844 NCBI chr 2:1,789,113...2,331,388
Ensembl chr 2:1,789,113...2,331,664 		JBrowse link
G N4BP2L1 NEDD4 binding protein 2 like 1 increases expression EXP clothianidin results in increased expression of N4BP2L1 mRNA CTD PMID:31626844 NCBI chr13:32,400,723...32,429,616
Ensembl chr13:32,400,723...32,428,311 		JBrowse link
G NADSYN1 NAD synthetase 1 decreases expression EXP clothianidin results in decreased expression of NADSYN1 mRNA CTD PMID:31626844 NCBI chr11:71,453,203...71,501,816
Ensembl chr11:71,453,109...71,524,107 		JBrowse link
G NASP nuclear autoantigenic sperm protein decreases expression EXP clothianidin results in decreased expression of NASP mRNA CTD PMID:31626844 NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904 		JBrowse link
G NDUFA10 NADH:ubiquinone oxidoreductase subunit A10 increases expression EXP clothianidin results in increased expression of NDUFA10 mRNA CTD PMID:31626844 NCBI chr 2:239,892,442...240,025,343
Ensembl chr 2:239,892,450...240,025,345
Ensembl chr 2:239,892,450...240,025,345 		JBrowse link
G NEUROD4 neuronal differentiation 4 decreases expression EXP clothianidin results in decreased expression of NEUROD4 mRNA CTD PMID:31626844 NCBI chr12:55,019,974...55,030,017
Ensembl chr12:55,019,974...55,030,017 		JBrowse link
G NGEF neuronal guanine nucleotide exchange factor increases expression EXP clothianidin results in increased expression of NGEF mRNA CTD PMID:31626844 NCBI chr 2:232,878,686...233,013,256
Ensembl chr 2:232,878,701...233,013,256 		JBrowse link
G NGFR nerve growth factor receptor increases expression EXP clothianidin results in increased expression of NGFR mRNA CTD PMID:29044138 NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008 		JBrowse link
G NLRP13 NLR family pyrin domain containing 13 decreases expression EXP clothianidin results in decreased expression of NLRP13 mRNA CTD PMID:31626844 NCBI chr19:55,891,692...55,932,336
Ensembl chr19:55,891,699...55,932,336 		JBrowse link
G NOS2 nitric oxide synthase 2 increases expression EXP clothianidin results in increased expression of NOS2 mRNA CTD PMID:31626844 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 multiple interactions
decreases expression		 EXP [clothianidin co-treated with enilconazole] results in decreased expression of NR0B2 mRNA
clothianidin results in decreased expression of NR0B2 mRNA		 CTD PMID:32201337 NCBI chr 1:26,911,489...26,914,110
Ensembl chr 1:26,911,489...26,913,975 		JBrowse link
G NTN4 netrin 4 decreases expression EXP clothianidin results in decreased expression of NTN4 mRNA CTD PMID:31626844 NCBI chr12:95,657,807...95,791,155
Ensembl chr12:95,657,807...95,791,152
Ensembl chr12:95,657,807...95,791,152 		JBrowse link
G NTS neurotensin decreases expression EXP clothianidin results in decreased expression of NTS mRNA CTD PMID:31626844 NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992 		JBrowse link
G NXNL2 nucleoredoxin like 2 increases expression EXP clothianidin results in increased expression of NXNL2 mRNA CTD PMID:31626844 NCBI chr 9:88,535,088...88,584,510
Ensembl chr 9:88,534,033...88,584,274 		JBrowse link
G NXPH2 neurexophilin 2 increases expression EXP clothianidin results in increased expression of NXPH2 mRNA CTD PMID:31626844 NCBI chr 2:138,669,157...138,780,390
Ensembl chr 2:138,669,157...138,780,390 		JBrowse link
G OCRL OCRL inositol polyphosphate-5-phosphatase decreases expression EXP clothianidin results in decreased expression of OCRL mRNA CTD PMID:31626844 NCBI chr  X:129,540,259...129,592,556
Ensembl chr  X:129,539,849...129,592,561 		JBrowse link
G OR1D4 olfactory receptor family 1 subfamily D member 4 increases expression EXP clothianidin results in increased expression of OR1D4 mRNA CTD PMID:31626844 NCBI chr17:3,240,676...3,241,614
Ensembl chr17:3,235,703...3,241,614 		JBrowse link
G OR51E2 olfactory receptor family 51 subfamily E member 2 increases expression EXP clothianidin results in increased expression of OR51E2 mRNA CTD PMID:31626844 NCBI chr11:4,680,171...4,697,853
Ensembl chr11:4,680,171...4,697,854 		JBrowse link
G OTUD6B OTU deubiquitinase 6B increases expression EXP clothianidin results in increased expression of OTUD6B mRNA CTD PMID:29044138 NCBI chr 8:91,070,305...91,087,095
Ensembl chr 8:91,070,196...91,087,095 		JBrowse link
G OXER1 oxoeicosanoid receptor 1 decreases expression EXP clothianidin results in decreased expression of OXER1 mRNA CTD PMID:29044138 NCBI chr 2:42,762,499...42,764,261
Ensembl chr 2:42,762,481...42,764,261 		JBrowse link
G PADI4 peptidyl arginine deiminase 4 increases expression EXP clothianidin results in increased expression of PADI4 mRNA CTD PMID:31626844 NCBI chr 1:17,308,195...17,364,004
Ensembl chr 1:17,308,195...17,364,004 		JBrowse link
G PAGE5 PAGE family member 5 decreases expression EXP clothianidin results in decreased expression of PAGE5 mRNA CTD PMID:31626844 NCBI chr  X:55,220,346...55,224,108
Ensembl chr  X:55,220,355...55,224,108
Ensembl chr  X:55,220,355...55,224,108 		JBrowse link
G PAK5 p21 (RAC1) activated kinase 5 decreases expression EXP clothianidin results in decreased expression of PAK5 mRNA CTD PMID:31626844 NCBI chr20:9,537,370...9,839,076
Ensembl chr20:9,537,389...9,839,041
Ensembl chr20:9,537,389...9,839,041 		JBrowse link
G PAQR8 progestin and adipoQ receptor family member 8 decreases expression EXP clothianidin results in decreased expression of PAQR8 mRNA CTD PMID:29044138 NCBI chr 6:52,362,151...52,407,777
Ensembl chr 6:52,361,421...52,407,777 		JBrowse link
G PBLD phenazine biosynthesis like protein domain containing decreases expression EXP clothianidin results in decreased expression of PBLD mRNA CTD PMID:31626844 NCBI chr10:68,282,660...68,332,958
Ensembl chr10:68,282,660...68,333,049 		JBrowse link
G PCCA propionyl-CoA carboxylase subunit alpha decreases expression EXP clothianidin results in decreased expression of PCCA mRNA CTD PMID:32201337 NCBI chr13:100,089,020...100,530,435
Ensembl chr13:100,089,015...100,530,437 		JBrowse link
G PCSK1 proprotein convertase subtilisin/kexin type 1 decreases expression EXP clothianidin results in decreased expression of PCSK1 mRNA CTD PMID:31626844 NCBI chr 5:96,390,333...96,433,248
Ensembl chr 5:96,390,333...96,434,143 		JBrowse link
G PDE10A phosphodiesterase 10A decreases expression EXP clothianidin results in decreased expression of PDE10A mRNA CTD PMID:31626844 NCBI chr 6:165,327,287...165,988,115
Ensembl chr 6:165,327,287...165,988,078 		JBrowse link
G PDE1C phosphodiesterase 1C increases expression EXP clothianidin results in increased expression of PDE1C mRNA CTD PMID:31626844 NCBI chr 7:31,616,777...32,428,224
Ensembl chr 7:31,751,179...32,428,131 		JBrowse link
G PDE4DIP phosphodiesterase 4D interacting protein increases expression EXP clothianidin results in increased expression of PDE4DIP mRNA CTD PMID:31626844 NCBI chr 1:148,808,198...149,051,277
Ensembl chr 1:148,808,181...149,048,286 		JBrowse link
G PDZD7 PDZ domain containing 7 decreases expression EXP clothianidin results in decreased expression of PDZD7 mRNA CTD PMID:29044138 NCBI chr10:101,007,679...101,031,145
Ensembl chr10:101,007,679...101,032,295 		JBrowse link
G PELI2 pellino E3 ubiquitin protein ligase family member 2 decreases expression EXP clothianidin results in decreased expression of PELI2 mRNA CTD PMID:31626844 NCBI chr14:56,118,329...56,301,586
Ensembl chr14:56,117,814...56,301,524 		JBrowse link
G PHETA2 PH domain containing endocytic trafficking adaptor 2 increases expression EXP clothianidin results in increased expression of FAM109B mRNA CTD PMID:31626844 NCBI chr22:42,074,244...42,079,438
Ensembl chr22:42,074,248...42,079,438 		JBrowse link
G PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta decreases expression EXP clothianidin results in decreased expression of PIK3C2B mRNA CTD PMID:31626844 NCBI chr 1:204,422,633...204,494,815
Ensembl chr 1:204,422,628...204,494,724 		JBrowse link
G PIP5K1C phosphatidylinositol-4-phosphate 5-kinase type 1 gamma decreases expression EXP clothianidin results in decreased expression of PIP5K1C mRNA CTD PMID:31626844 NCBI chr19:3,630,181...3,700,486
Ensembl chr19:3,630,183...3,700,479
Ensembl chr19:3,630,183...3,700,479 		JBrowse link
G PIP5KL1 phosphatidylinositol-4-phosphate 5-kinase like 1 decreases expression EXP clothianidin results in decreased expression of PIP5KL1 mRNA CTD PMID:29044138 NCBI chr 9:127,920,881...127,931,958
Ensembl chr 9:127,920,881...127,930,785 		JBrowse link
G PLA2G2A phospholipase A2 group IIA increases expression EXP clothianidin results in increased expression of PLA2G2A mRNA CTD PMID:31626844 NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416 		JBrowse link
G PLBD1 phospholipase B domain containing 1 decreases expression EXP clothianidin results in decreased expression of PLBD1 mRNA CTD PMID:31626844 NCBI chr12:14,503,661...14,567,883
Ensembl chr12:14,503,661...14,567,883 		JBrowse link
G PLCD1 phospholipase C delta 1 increases expression EXP clothianidin results in increased expression of PLCD1 mRNA CTD PMID:31626844 NCBI chr 3:38,007,496...38,029,642
Ensembl chr 3:38,007,496...38,029,642
Ensembl chr 3:38,007,496...38,029,642 		JBrowse link
G PLCD3 phospholipase C delta 3 decreases expression EXP clothianidin results in decreased expression of PLCD3 mRNA CTD PMID:31626844 NCBI chr17:45,108,959...45,132,524
Ensembl chr17:45,108,959...45,133,354 		JBrowse link
G PLCL1 phospholipase C like 1 (inactive) decreases expression EXP clothianidin results in decreased expression of PLCL1 mRNA CTD PMID:31626844 NCBI chr 2:197,804,593...198,149,873
Ensembl chr 2:197,804,593...198,572,581 		JBrowse link
G PLLP plasmolipin increases expression EXP clothianidin results in increased expression of PLLP mRNA CTD PMID:31626844 NCBI chr16:57,256,097...57,284,672
Ensembl chr16:57,248,547...57,284,672 		JBrowse link
G PNPLA1 patatin like phospholipase domain containing 1 increases expression EXP clothianidin results in increased expression of PNPLA1 mRNA CTD PMID:31626844 NCBI chr 6:36,242,523...36,313,955
Ensembl chr 6:36,243,203...36,312,229 		JBrowse link
G POLR2M RNA polymerase II subunit M decreases expression EXP clothianidin results in decreased expression of POLR2M mRNA CTD PMID:31626844 NCBI chr15:57,706,714...57,717,557
Ensembl chr15:57,706,695...57,782,762 		JBrowse link
G PPP1R3C protein phosphatase 1 regulatory subunit 3C increases expression EXP clothianidin results in increased expression of PPP1R3C mRNA CTD PMID:29044138 NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071 		JBrowse link
G PPP3CC protein phosphatase 3 catalytic subunit gamma increases expression EXP clothianidin results in increased expression of PPP3CC mRNA CTD PMID:31626844 NCBI chr 8:22,441,053...22,541,466
Ensembl chr 8:22,440,819...22,541,142 		JBrowse link
G PRG3 proteoglycan 3, pro eosinophil major basic protein 2 increases expression EXP clothianidin results in increased expression of PRG3 mRNA CTD PMID:31626844 NCBI chr11:57,376,769...57,381,150
Ensembl chr11:57,376,769...57,381,150 		JBrowse link
G PRLR prolactin receptor decreases expression EXP clothianidin results in decreased expression of PRLR mRNA CTD PMID:29044138 NCBI chr 5:35,048,756...35,230,724
Ensembl chr 5:35,048,756...35,230,487 		JBrowse link
G PRND prion like protein doppel increases expression EXP clothianidin results in increased expression of PRND mRNA CTD PMID:31626844 NCBI chr20:4,721,909...4,728,460
Ensembl chr20:4,721,909...4,728,460 		JBrowse link
G PRODH2 proline dehydrogenase 2 increases expression EXP clothianidin results in increased expression of PRODH2 mRNA CTD PMID:31626844 NCBI chr19:35,799,988...35,812,845
Ensembl chr19:35,799,988...35,813,299 		JBrowse link
G PRR5-ARHGAP8 PRR5-ARHGAP8 readthrough increases expression EXP clothianidin results in increased expression of PRR5-ARHGAP8 mRNA CTD PMID:31626844 NCBI chr22:44,702,204...44,862,784
Ensembl chr22:44,702,233...44,862,706 		JBrowse link
G PRR5L proline rich 5 like increases expression EXP clothianidin results in increased expression of PRR5L mRNA CTD PMID:31626844 NCBI chr11:36,296,288...36,465,204
Ensembl chr11:36,296,288...36,465,204 		JBrowse link
G PRXL2B peroxiredoxin like 2B decreases expression EXP clothianidin results in decreased expression of PRXL2B mRNA CTD PMID:31626844 NCBI chr 1:2,586,523...2,591,469
Ensembl chr 1:2,586,491...2,591,469 		JBrowse link
G PSMC6 proteasome 26S subunit, ATPase 6 decreases expression EXP clothianidin results in decreased expression of PSMC6 mRNA CTD PMID:31626844 NCBI chr14:52,707,163...52,728,590
Ensembl chr14:52,707,178...52,728,590 		JBrowse link
G PSMD6-AS2 PSMD6 antisense RNA 2 decreases expression EXP clothianidin results in decreased expression of PSMD6-AS2 mRNA CTD PMID:29044138 NCBI chr 3:64,004,022...64,012,243
Ensembl chr 3:64,004,022...64,012,148 		JBrowse link
G PTGFR prostaglandin F receptor decreases expression EXP clothianidin results in decreased expression of PTGFR mRNA CTD PMID:31626844 NCBI chr 1:78,490,974...78,540,701
Ensembl chr 1:78,303,884...78,540,701 		JBrowse link
G PTPN3 protein tyrosine phosphatase non-receptor type 3 increases expression EXP clothianidin results in increased expression of PTPN3 mRNA CTD PMID:29044138 NCBI chr 9:109,375,694...109,538,395
Ensembl chr 9:109,375,466...109,498,313 		JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B decreases expression EXP clothianidin results in decreased expression of PTPRB mRNA CTD PMID:31626844 NCBI chr12:70,515,870...70,637,440
Ensembl chr12:70,515,866...70,637,440
Ensembl chr12:70,515,866...70,637,440 		JBrowse link
G PTPRO protein tyrosine phosphatase receptor type O decreases expression EXP clothianidin results in decreased expression of PTPRO mRNA CTD PMID:29044138 NCBI chr12:15,322,334...15,598,331
Ensembl chr12:15,322,508...15,598,331
Ensembl chr12:15,322,508...15,598,331 		JBrowse link
G QPCT glutaminyl-peptide cyclotransferase increases expression EXP clothianidin results in increased expression of QPCT mRNA CTD PMID:31626844 NCBI chr 2:37,344,630...37,373,322
Ensembl chr 2:37,342,827...37,373,322 		JBrowse link
G RAET1L retinoic acid early transcript 1L increases expression EXP clothianidin results in increased expression of RAET1L mRNA CTD PMID:31626844 NCBI chr 6:150,018,334...150,025,532
Ensembl chr 6:150,018,334...150,025,532 		JBrowse link
G RAG1 recombination activating 1 decreases expression EXP clothianidin results in decreased expression of RAG1 mRNA CTD PMID:31626844 NCBI chr11:36,510,353...36,579,762
Ensembl chr11:36,510,709...36,593,156 		JBrowse link
G RAPGEFL1 Rap guanine nucleotide exchange factor like 1 decreases expression EXP clothianidin results in decreased expression of RAPGEFL1 mRNA CTD PMID:29044138 NCBI chr17:40,177,010...40,195,655
Ensembl chr17:40,177,010...40,195,656 		JBrowse link
G RBM26 RNA binding motif protein 26 decreases expression EXP clothianidin results in decreased expression of RBM26 mRNA CTD PMID:31626844 NCBI chr13:79,311,827...79,406,255
Ensembl chr13:79,311,824...79,406,477 		JBrowse link
G RBMS1 RNA binding motif single stranded interacting protein 1 decreases expression EXP clothianidin results in decreased expression of RBMS1 mRNA CTD PMID:31626844 NCBI chr 2:160,272,151...160,493,983
Ensembl chr 2:160,272,151...160,493,807 		JBrowse link
G REG3G regenerating family member 3 gamma increases expression EXP clothianidin results in increased expression of REG3G mRNA CTD PMID:31626844 NCBI chr 2:79,025,664...79,028,502
Ensembl chr 2:79,025,686...79,028,505 		JBrowse link
G RFESD Rieske Fe-S domain containing decreases expression EXP clothianidin results in decreased expression of RFESD mRNA CTD PMID:31626844 NCBI chr 5:95,646,777...95,658,082
Ensembl chr 5:95,646,754...95,684,773 		JBrowse link
G RIIAD1 regulatory subunit of type II PKA R-subunit domain containing 1 decreases expression EXP clothianidin results in decreased expression of RIIAD1 mRNA CTD PMID:31626844 NCBI chr 1:151,721,522...151,729,805
Ensembl chr 1:151,710,433...151,729,805 		JBrowse link
G RND1 Rho family GTPase 1 increases expression EXP clothianidin results in increased expression of RND1 mRNA CTD PMID:29044138 NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870 		JBrowse link
G RP1L1 RP1 like 1 increases expression EXP clothianidin results in increased expression of RP1L1 mRNA CTD PMID:31626844 NCBI chr 8:10,606,349...10,655,143
Ensembl chr 8:10,606,349...10,712,187 		JBrowse link
G RPS29 ribosomal protein S29 increases expression EXP clothianidin results in increased expression of RPS29 mRNA CTD PMID:31626844 NCBI chr14:49,570,988...49,598,710
Ensembl chr14:49,570,984...49,599,164 		JBrowse link
G S100A5 S100 calcium binding protein A5 decreases expression EXP clothianidin results in decreased expression of S100A5 mRNA CTD PMID:31626844 NCBI chr 1:153,537,114...153,543,514
Ensembl chr 1:153,537,147...153,541,765 		JBrowse link
G SASH3 SAM and SH3 domain containing 3 increases expression EXP clothianidin results in increased expression of SASH3 mRNA CTD PMID:31626844 NCBI chr  X:129,779,949...129,795,201
Ensembl chr  X:129,779,949...129,795,201 		JBrowse link
G SCN7A sodium voltage-gated channel alpha subunit 7 decreases expression EXP clothianidin results in decreased expression of SCN7A mRNA CTD PMID:31626844 NCBI chr 2:166,403,573...166,494,264
Ensembl chr 2:166,403,573...166,611,482 		JBrowse link
G SCNN1B sodium channel epithelial 1 subunit beta increases expression EXP clothianidin results in increased expression of SCNN1B mRNA CTD PMID:31626844 NCBI chr16:23,278,231...23,381,295
Ensembl chr16:23,278,231...23,381,294 		JBrowse link
G SEMA3F semaphorin 3F decreases expression EXP clothianidin results in decreased expression of SEMA3F mRNA CTD PMID:31626844 NCBI chr 3:50,155,058...50,189,075
Ensembl chr 3:50,155,045...50,189,075 		JBrowse link
G SERP1 stress associated endoplasmic reticulum protein 1 decreases expression EXP clothianidin results in decreased expression of SERP1 mRNA CTD PMID:31626844 NCBI chr 3:150,541,998...150,546,496
Ensembl chr 3:150,541,998...150,603,228 		JBrowse link
G SERPINA13P serpin family A member 13, pseudogene increases expression EXP clothianidin results in increased expression of SERPINA13P mRNA CTD PMID:31626844 NCBI chr14:94,640,725...94,646,994
Ensembl chr14:94,640,725...94,646,994 		JBrowse link
G SERPINC1 serpin family C member 1 decreases expression EXP clothianidin results in decreased expression of SERPINC1 mRNA CTD PMID:31626844 NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,804...173,917,378
Ensembl chr 1:173,903,804...173,917,378 		JBrowse link
G SERPINE1 serpin family E member 1 decreases expression EXP clothianidin results in decreased expression of SERPINE1 mRNA CTD PMID:31626844 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247 		JBrowse link
G SGCD sarcoglycan delta increases expression EXP clothianidin results in increased expression of SGCD mRNA CTD PMID:31626844 NCBI chr 5:155,728,636...156,767,788
Ensembl chr 5:155,870,344...156,767,788 		JBrowse link
G SGK2 serum/glucocorticoid regulated kinase 2 decreases expression EXP clothianidin results in decreased expression of SGK2 mRNA CTD PMID:29044138 NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237 		JBrowse link
G SH3TC1 SH3 domain and tetratricopeptide repeats 1 increases expression EXP clothianidin results in increased expression of SH3TC1 mRNA CTD PMID:29044138 NCBI chr 4:8,182,072...8,241,103
Ensembl chr 4:8,182,072...8,241,803 		JBrowse link
G SHANK2-AS3 SHANK2 antisense RNA 3 increases expression EXP clothianidin results in increased expression of SHANK2-AS3 mRNA CTD PMID:31626844 NCBI chr11:70,862,790...70,865,115
Ensembl chr11:70,862,790...70,865,115 		JBrowse link
G SIK1B salt inducible kinase 1B (putative) increases expression EXP clothianidin results in increased expression of SIK1B mRNA CTD PMID:29044138 NCBI chr21:6,111,131...6,123,778
Ensembl chr21:6,111,131...6,123,778 		JBrowse link
G SIPA1L2 signal induced proliferation associated 1 like 2 increases expression EXP clothianidin results in increased expression of SIPA1L2 mRNA CTD PMID:29044138 NCBI chr 1:232,397,965...232,630,496
Ensembl chr 1:232,397,965...232,630,571
Ensembl chr 1:232,397,965...232,630,571 		JBrowse link
G SIRPB1 signal regulatory protein beta 1 increases expression EXP clothianidin results in increased expression of SIRPB1 mRNA CTD PMID:31626844 NCBI chr20:1,561,385...1,620,447
Ensembl chr20:1,563,521...1,620,061
Ensembl chr20:1,563,521...1,620,061 		JBrowse link
G SLC14A1 solute carrier family 14 member 1 (Kidd blood group) decreases expression EXP clothianidin results in decreased expression of SLC14A1 mRNA CTD PMID:31626844 NCBI chr18:45,724,127...45,752,520
Ensembl chr18:45,687,025...45,752,520 		JBrowse link
G SLC17A7 solute carrier family 17 member 7 decreases expression EXP clothianidin results in decreased expression of SLC17A7 mRNA CTD PMID:31626844 NCBI chr19:49,429,401...49,441,527
Ensembl chr19:49,429,401...49,442,360 		JBrowse link
G SLC22A2 solute carrier family 22 member 2 decreases activity EXP clothianidin results in decreased activity of SLC22A2 protein CTD PMID:31364238 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638 		JBrowse link
G SLC22A6 solute carrier family 22 member 6 decreases activity EXP clothianidin results in decreased activity of SLC22A6 protein CTD PMID:31364238 NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
Ensembl chr11:62,936,385...62,984,967 		JBrowse link
G SLC22A8 solute carrier family 22 member 8 decreases activity EXP clothianidin results in decreased activity of SLC22A8 protein CTD PMID:31364238 NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841 		JBrowse link
G SLC28A1 solute carrier family 28 member 1 increases expression EXP clothianidin results in increased expression of SLC28A1 mRNA CTD PMID:31626844 NCBI chr15:84,884,350...84,975,649
Ensembl chr15:84,884,654...84,945,798 		JBrowse link
G SLC38A9 solute carrier family 38 member 9 decreases expression EXP clothianidin results in decreased expression of SLC38A9 mRNA CTD PMID:31626844 NCBI chr 5:55,625,845...55,712,343
Ensembl chr 5:55,625,845...55,773,194 		JBrowse link
G SLC45A2 solute carrier family 45 member 2 decreases expression EXP clothianidin results in decreased expression of SLC45A2 mRNA CTD PMID:31626844 NCBI chr 5:33,944,623...33,984,693
Ensembl chr 5:33,944,623...33,984,693 		JBrowse link
G SLC47A2 solute carrier family 47 member 2 decreases activity EXP clothianidin results in decreased activity of SLC47A2 protein CTD PMID:31364238 NCBI chr17:19,678,313...19,719,598
Ensembl chr17:19,678,288...19,718,979 		JBrowse link
G SLC48A1 solute carrier family 48 member 1 increases expression EXP clothianidin results in increased expression of SLC48A1 mRNA CTD PMID:31626844 NCBI chr12:47,753,619...47,782,753
Ensembl chr12:47,753,916...47,782,751 		JBrowse link
G SLCO1C1 solute carrier organic anion transporter family member 1C1 increases expression EXP clothianidin results in increased expression of SLCO1C1 mRNA CTD PMID:31626844 NCBI chr12:20,681,800...20,753,386
Ensembl chr12:20,695,332...20,753,386
Ensembl chr12:20,695,332...20,753,386 		JBrowse link
G SORBS1 sorbin and SH3 domain containing 1 increases expression EXP clothianidin results in increased expression of SORBS1 mRNA CTD PMID:31626844 NCBI chr10:95,311,773...95,561,439
Ensembl chr10:95,311,771...95,561,414 		JBrowse link
G SPANXD SPANX family member D increases expression EXP clothianidin results in increased expression of SPANXD mRNA CTD PMID:31626844 NCBI chr  X:141,697,411...141,698,739
Ensembl chr  X:141,697,411...141,698,739 		JBrowse link
G SPATA3 spermatogenesis associated 3 increases expression EXP clothianidin results in increased expression of SPATA3 mRNA CTD PMID:31626844 NCBI chr 2:230,996,121...231,019,938
Ensembl chr 2:230,990,324...231,025,055 		JBrowse link
G SPIRE2 spire type actin nucleation factor 2 decreases expression EXP clothianidin results in decreased expression of SPIRE2 mRNA CTD PMID:29044138 NCBI chr16:89,828,475...89,871,319
Ensembl chr16:89,818,179...89,871,319 		JBrowse link
G SRD5A2 steroid 5 alpha-reductase 2 increases expression EXP clothianidin results in increased expression of SRD5A2 mRNA CTD PMID:31626844 NCBI chr 2:31,522,480...31,665,651
Ensembl chr 2:31,522,480...31,580,938 		JBrowse link
G SSPOP SCO-spondin, pseudogene decreases expression EXP clothianidin results in decreased expression of SSPOP mRNA CTD PMID:29044138 NCBI chr 7:149,776,042...149,833,965
Ensembl chr 7:149,776,042...149,833,979 		JBrowse link
G STAC2 SH3 and cysteine rich domain 2 increases expression EXP clothianidin results in increased expression of STAC2 mRNA CTD PMID:31626844 NCBI chr17:39,210,536...39,225,945
Ensembl chr17:39,210,541...39,225,945 		JBrowse link
G STEAP2 STEAP2 metalloreductase increases expression EXP clothianidin results in increased expression of STEAP2 mRNA CTD PMID:31626844 NCBI chr 7:90,211,740...90,243,408
Ensembl chr 7:90,167,590...90,238,137 		JBrowse link
G SUSD4 sushi domain containing 4 increases expression EXP clothianidin results in increased expression of SUSD4 mRNA CTD PMID:31626844 NCBI chr 1:223,220,826...223,365,271
Ensembl chr 1:223,220,819...223,364,178 		JBrowse link
G SYCP2 synaptonemal complex protein 2 decreases expression EXP clothianidin results in decreased expression of SYCP2 mRNA CTD PMID:29044138 NCBI chr20:59,863,277...59,933,700
Ensembl chr20:59,863,564...59,933,655 		JBrowse link
G SYNPO synaptopodin decreases expression EXP clothianidin results in decreased expression of SYNPO mRNA CTD PMID:29044138 NCBI chr 5:150,586,026...150,659,214
Ensembl chr 5:150,601,080...150,659,207 		JBrowse link
G TACR1 tachykinin receptor 1 increases expression EXP clothianidin results in increased expression of TACR1 mRNA CTD PMID:31626844 NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520 		JBrowse link
G TAF1L TATA-box binding protein associated factor 1 like decreases expression EXP clothianidin results in decreased expression of TAF1L mRNA CTD PMID:31626844 NCBI chr 9:32,629,454...32,635,669
Ensembl chr 9:32,629,454...32,635,669 		JBrowse link
G TAFA2 TAFA chemokine like family member 2 decreases expression EXP clothianidin results in decreased expression of FAM19A2 mRNA CTD PMID:31626844 NCBI chr12:61,708,273...62,260,104
Ensembl chr12:61,708,259...62,279,150 		JBrowse link
G TAFA5 TAFA chemokine like family member 5 increases expression EXP clothianidin results in increased expression of FAM19A5 mRNA CTD PMID:31626844 NCBI chr22:48,489,553...48,751,932
Ensembl chr22:48,489,460...48,850,912
Ensembl chr22:48,489,460...48,850,912 		JBrowse link
G TBX2 T-box transcription factor 2 increases expression EXP clothianidin results in increased expression of TBX2 mRNA CTD PMID:29044138 NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466 		JBrowse link
G TCP10L2 t-complex 10 like 2, pseudogene increases expression EXP clothianidin results in increased expression of TCP10L2 mRNA CTD PMID:31626844 NCBI chr 6:167,170,742...167,193,707
Ensembl chr 6:167,146,414...167,196,913 		JBrowse link
G TECPR1 tectonin beta-propeller repeat containing 1 decreases expression EXP clothianidin results in decreased expression of TECPR1 mRNA CTD PMID:31626844 NCBI chr 7:98,214,624...98,252,235
Ensembl chr 7:98,214,624...98,252,232 		JBrowse link
G TEF TEF transcription factor, PAR bZIP family member increases expression EXP clothianidin results in increased expression of TEF mRNA CTD PMID:31626844 NCBI chr22:41,367,455...41,399,326
Ensembl chr22:41,367,333...41,399,326 		JBrowse link
G TGFBI transforming growth factor beta induced increases expression EXP clothianidin results in increased expression of TGFBI mRNA CTD PMID:31626844 NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818 		JBrowse link
G TGM5 transglutaminase 5 decreases expression EXP clothianidin results in decreased expression of TGM5 mRNA CTD PMID:29044138 NCBI chr15:43,232,590...43,266,928
Ensembl chr15:43,232,590...43,266,928 		JBrowse link
G THAP9 THAP domain containing 9 increases expression EXP clothianidin results in increased expression of THAP9 mRNA CTD PMID:31626844 NCBI chr 4:82,900,684...82,920,283
Ensembl chr 4:82,900,684...82,919,969 		JBrowse link
G TIFA TRAF interacting protein with forkhead associated domain increases expression EXP clothianidin results in increased expression of TIFA mRNA CTD PMID:31626844 NCBI chr 4:112,274,537...112,285,904
Ensembl chr 4:112,274,537...112,285,904 		JBrowse link
G TLCD4 TLC domain containing 4 increases expression EXP clothianidin results in increased expression of TLCD4 mRNA CTD PMID:29044138 NCBI chr 1:95,092,517...95,197,607
Ensembl chr 1:95,117,355...95,197,607 		JBrowse link
G TLX3 T cell leukemia homeobox 3 decreases expression EXP clothianidin results in decreased expression of TLX3 mRNA CTD PMID:31626844 NCBI chr 5:171,309,248...171,312,139
Ensembl chr 5:171,309,248...171,312,139 		JBrowse link
G TMEM273 transmembrane protein 273 increases expression EXP clothianidin results in increased expression of C10ORF128 mRNA CTD PMID:31626844 NCBI chr10:49,154,728...49,188,580
Ensembl chr10:49,154,725...49,188,585 		JBrowse link
G TMEM38A transmembrane protein 38A decreases expression EXP clothianidin results in decreased expression of TMEM38A mRNA CTD PMID:29044138 NCBI chr19:16,661,139...16,690,023
Ensembl chr19:16,661,139...16,690,023 		JBrowse link
G TMEM71 transmembrane protein 71 decreases expression EXP clothianidin results in decreased expression of TMEM71 mRNA CTD PMID:31626844 NCBI chr 8:132,705,839...132,775,999
Ensembl chr 8:132,685,007...132,760,712 		JBrowse link
G TNF tumor necrosis factor multiple interactions EXP clothianidin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; clothianidin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] CTD PMID:29044138 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFRSF11B TNF receptor superfamily member 11b decreases expression EXP clothianidin results in decreased expression of TNFRSF11B mRNA CTD PMID:31626844 NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885 		JBrowse link
G TNXB tenascin XB decreases expression EXP clothianidin results in decreased expression of TNXB mRNA CTD PMID:29044138 NCBI chr 6:32,041,153...32,109,338
Ensembl chr 6:32,041,153...32,115,334 		JBrowse link
G TPM1 tropomyosin 1 increases expression EXP clothianidin results in increased expression of TPM1 mRNA CTD PMID:29044138 NCBI chr15:63,042,698...63,071,915
Ensembl chr15:63,042,632...63,071,915 		JBrowse link
G TRAF4 TNF receptor associated factor 4 increases expression EXP clothianidin results in increased expression of TRAF4 mRNA CTD PMID:29044138 NCBI chr17:28,744,004...28,750,956
Ensembl chr17:28,744,005...28,750,956 		JBrowse link
G TRAF6 TNF receptor associated factor 6 decreases expression EXP clothianidin results in decreased expression of TRAF6 mRNA CTD PMID:29044138 NCBI chr11:36,483,769...36,510,313
Ensembl chr11:36,483,769...36,510,272 		JBrowse link
G TRAPPC4 trafficking protein particle complex 4 increases expression EXP clothianidin results in increased expression of TRAPPC4 mRNA CTD PMID:31626844 NCBI chr11:119,018,766...119,024,134
Ensembl chr11:119,018,763...119,025,454 		JBrowse link
G TRIM37 tripartite motif containing 37 decreases expression EXP clothianidin results in decreased expression of TRIM37 mRNA CTD PMID:31626844 NCBI chr17:58,968,010...59,106,880
Ensembl chr17:58,982,638...59,106,921 		JBrowse link
G TRMT44 tRNA methyltransferase 44 homolog increases expression EXP clothianidin results in increased expression of TRMT44 mRNA CTD PMID:31626844 NCBI chr 4:8,440,774...8,512,531
Ensembl chr 4:8,436,140...8,493,531 		JBrowse link
G TSSK6 testis specific serine kinase 6 decreases expression EXP clothianidin results in decreased expression of TSSK6 mRNA CTD PMID:31626844 NCBI chr19:19,514,219...19,515,548
Ensembl chr19:19,512,418...19,515,548 		JBrowse link
G TTC28 tetratricopeptide repeat domain 28 decreases expression EXP clothianidin results in decreased expression of TTC28 mRNA CTD PMID:31626844 NCBI chr22:27,978,014...28,679,865
Ensembl chr22:27,978,014...28,679,865 		JBrowse link
G TTC30B tetratricopeptide repeat domain 30B decreases expression EXP clothianidin results in decreased expression of TTC30B mRNA CTD PMID:31626844 NCBI chr 2:177,548,998...177,552,796
Ensembl chr 2:177,548,998...177,552,796 		JBrowse link
G TTC33 tetratricopeptide repeat domain 33 decreases expression EXP clothianidin results in decreased expression of TTC33 mRNA CTD PMID:31626844 NCBI chr 5:40,711,576...40,755,961
Ensembl chr 5:40,512,333...40,755,963 		JBrowse link
G TTC8 tetratricopeptide repeat domain 8 decreases expression EXP clothianidin results in decreased expression of TTC8 mRNA CTD PMID:31626844 NCBI chr14:88,824,153...88,881,079
Ensembl chr14:88,824,153...88,881,078 		JBrowse link
G TUBGCP3 tubulin gamma complex associated protein 3 increases expression EXP clothianidin results in increased expression of TUBGCP3 mRNA CTD PMID:31626844 NCBI chr13:112,485,005...112,606,469
Ensembl chr13:112,485,011...112,588,205 		JBrowse link
G TXNDC2 thioredoxin domain containing 2 increases expression EXP clothianidin results in increased expression of TXNDC2 mRNA CTD PMID:31626844 NCBI chr18:9,885,973...9,889,275
Ensembl chr18:9,885,726...9,889,275 		JBrowse link
G UBAP1L ubiquitin associated protein 1 like decreases expression
increases expression		 EXP clothianidin results in decreased expression of UBAP1L mRNA
clothianidin results in increased expression of UBAP1L mRNA		 CTD PMID:29044138 PMID:31626844 NCBI chr15:65,083,036...65,115,200
Ensembl chr15:65,092,770...65,115,197
Ensembl chr15:65,092,770...65,115,197 		JBrowse link
G UNC119B unc-119 lipid binding chaperone B increases expression EXP clothianidin results in increased expression of UNC119B mRNA CTD PMID:31626844 NCBI chr12:120,710,458...120,723,640
Ensembl chr12:120,710,458...120,723,640 		JBrowse link
G USP43 ubiquitin specific peptidase 43 decreases expression EXP clothianidin results in decreased expression of USP43 mRNA CTD PMID:31626844 NCBI chr17:9,643,493...9,729,687
Ensembl chr17:9,644,698...9,729,687 		JBrowse link
G UTRN utrophin decreases expression EXP clothianidin results in decreased expression of UTRN mRNA CTD PMID:31626844 NCBI chr 6:144,284,955...144,853,034
Ensembl chr 6:144,285,701...144,853,034 		JBrowse link
G VAMP8 vesicle associated membrane protein 8 increases expression EXP clothianidin results in increased expression of VAMP8 mRNA CTD PMID:31626844 NCBI chr 2:85,577,535...85,582,031
Ensembl chr 2:85,561,562...85,582,031 		JBrowse link
G VEGFD vascular endothelial growth factor D decreases expression EXP clothianidin results in decreased expression of VEGFD mRNA CTD PMID:31626844 NCBI chr  X:15,345,596...15,384,413
Ensembl chr  X:15,345,596...15,384,413 		JBrowse link
G VPS8 VPS8 subunit of CORVET complex decreases expression EXP clothianidin results in decreased expression of VPS8 mRNA CTD PMID:31626844 NCBI chr 3:184,812,143...185,052,614
Ensembl chr 3:184,812,143...185,052,614 		JBrowse link
G WASHC4 WASH complex subunit 4 increases expression EXP clothianidin results in increased expression of WASHC4 mRNA CTD PMID:31626844 NCBI chr12:105,107,726...105,169,134
Ensembl chr12:105,107,324...105,169,134
Ensembl chr12:105,107,324...105,169,134 		JBrowse link
G WHRN whirlin increases expression EXP clothianidin results in increased expression of WHRN mRNA CTD PMID:31626844 NCBI chr 9:114,402,078...114,505,500
Ensembl chr 9:114,402,080...114,505,473 		JBrowse link
G XAGE3 X antigen family member 3 increases expression EXP clothianidin results in increased expression of XAGE3 mRNA CTD PMID:31626844 NCBI chr  X:52,862,528...52,868,140
Ensembl chr  X:52,862,525...52,868,083 		JBrowse link
G YPEL2 yippee like 2 increases expression EXP clothianidin results in increased expression of YPEL2 mRNA CTD PMID:31626844 NCBI chr17:59,331,655...59,401,732
Ensembl chr17:59,331,655...59,401,729 		JBrowse link
G YPEL3 yippee like 3 decreases expression EXP clothianidin results in decreased expression of YPEL3 mRNA CTD PMID:29044138 NCBI chr16:30,092,314...30,096,213
Ensembl chr16:30,092,314...30,096,915 		JBrowse link
G ZBTB45 zinc finger and BTB domain containing 45 decreases expression EXP clothianidin results in decreased expression of ZBTB45 mRNA CTD PMID:31626844 NCBI chr19:58,513,530...58,542,718
Ensembl chr19:58,513,530...58,538,911 		JBrowse link
G ZCCHC13 zinc finger CCHC-type containing 13 decreases expression EXP clothianidin results in decreased expression of ZCCHC13 mRNA CTD PMID:31626844 NCBI chr  X:74,304,180...74,305,034
Ensembl chr  X:74,304,180...74,305,034 		JBrowse link
G ZDHHC11B zinc finger DHHC-type containing 11B decreases expression EXP clothianidin results in decreased expression of ZDHHC11B mRNA CTD PMID:31626844 NCBI chr 5:710,355...784,749
Ensembl chr 5:716,808...766,919
Ensembl chr 5:716,808...766,919 		JBrowse link
G ZKSCAN7 zinc finger with KRAB and SCAN domains 7 increases expression EXP clothianidin results in increased expression of ZKSCAN7 mRNA CTD PMID:31626844 NCBI chr 3:44,555,193...44,583,483
Ensembl chr 3:44,555,193...44,594,173 		JBrowse link
G ZNF141 zinc finger protein 141 decreases expression EXP clothianidin results in decreased expression of ZNF141 mRNA CTD PMID:31626844 NCBI chr 4:337,814...384,868
Ensembl chr 4:337,814...384,868 		JBrowse link
G ZNF18 zinc finger protein 18 decreases expression EXP clothianidin results in decreased expression of ZNF18 mRNA CTD PMID:31626844 NCBI chr17:11,957,433...12,021,522
Ensembl chr17:11,977,439...11,997,475 		JBrowse link
G ZNF20 zinc finger protein 20 increases expression EXP clothianidin results in increased expression of ZNF20 mRNA CTD PMID:31626844 NCBI chr19:12,131,350...12,140,350
Ensembl chr19:12,092,843...12,140,355 		JBrowse link
G ZNF200 zinc finger protein 200 decreases expression EXP clothianidin results in decreased expression of ZNF200 mRNA CTD PMID:31626844 NCBI chr16:3,222,325...3,236,221
Ensembl chr16:3,222,325...3,236,221 		JBrowse link
G ZNF219 zinc finger protein 219 decreases expression EXP clothianidin results in decreased expression of ZNF219 mRNA CTD PMID:29044138 NCBI chr14:21,090,076...21,104,722
Ensembl chr14:21,090,077...21,104,722 		JBrowse link
G ZNF273 zinc finger protein 273 decreases expression EXP clothianidin results in decreased expression of ZNF273 mRNA CTD PMID:31626844 NCBI chr 7:64,877,603...64,932,239
Ensembl chr 7:64,870,172...64,930,966 		JBrowse link
G ZNF467 zinc finger protein 467 increases expression EXP clothianidin results in increased expression of ZNF467 mRNA CTD PMID:31626844 NCBI chr 7:149,764,182...149,776,323
Ensembl chr 7:149,764,182...149,773,588 		JBrowse link
G ZNF470 zinc finger protein 470 increases expression EXP clothianidin results in increased expression of ZNF470 mRNA CTD PMID:31626844 NCBI chr19:56,567,468...56,582,894
Ensembl chr19:56,567,468...56,588,911 		JBrowse link
G ZNF501 zinc finger protein 501 decreases expression EXP clothianidin results in decreased expression of ZNF501 mRNA CTD PMID:31626844 NCBI chr 3:44,729,635...44,737,083
Ensembl chr 3:44,729,596...44,737,083 		JBrowse link
G ZNF502 zinc finger protein 502 increases expression EXP clothianidin results in increased expression of ZNF502 mRNA CTD PMID:31626844 NCBI chr 3:44,712,660...44,723,831
Ensembl chr 3:44,712,643...44,723,831 		JBrowse link
G ZNF521 zinc finger protein 521 decreases expression EXP clothianidin results in decreased expression of ZNF521 mRNA CTD PMID:31626844 NCBI chr18:25,061,924...25,352,194
Ensembl chr18:25,061,924...25,352,190 		JBrowse link
G ZNF627 zinc finger protein 627 increases expression EXP clothianidin results in increased expression of ZNF627 mRNA CTD PMID:31626844 NCBI chr19:11,575,255...11,619,161
Ensembl chr19:11,559,374...11,619,161 		JBrowse link
G ZNF653 zinc finger protein 653 decreases expression EXP clothianidin results in decreased expression of ZNF653 mRNA CTD PMID:31626844 NCBI chr19:11,483,429...11,505,839
Ensembl chr19:11,483,427...11,505,839 		JBrowse link
G ZNF784 zinc finger protein 784 increases expression EXP clothianidin results in increased expression of ZNF784 mRNA CTD PMID:31626844 NCBI chr19:55,620,741...55,624,566
Ensembl chr19:55,620,741...55,624,566
Ensembl chr19:55,620,741...55,624,566 		JBrowse link
G ZNF875 zinc finger protein 875 increases expression EXP clothianidin results in increased expression of HKR1 mRNA CTD PMID:31626844 NCBI chr19:37,312,837...37,364,455
Ensembl chr19:37,312,837...37,369,365 		JBrowse link
G ZSWIM4 zinc finger SWIM-type containing 4 decreases expression EXP clothianidin results in decreased expression of ZSWIM4 mRNA CTD PMID:31626844 NCBI chr19:13,795,424...13,832,254
Ensembl chr19:13,795,460...13,832,230 		JBrowse link
dabigatran term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AIF1 allograft inflammatory factor 1 decreases expression ISO Dabigatran results in decreased expression of AIF1 protein CTD PMID:27397090 NCBI chr 6:31,615,212...31,617,015
Ensembl chr 6:31,615,217...31,617,021 		JBrowse link
G ALDH1A2 aldehyde dehydrogenase 1 family member A2 decreases expression EXP Dabigatran results in decreased expression of ALDH1A2 mRNA CTD PMID:31711903 NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866 		JBrowse link
G EYA1 EYA transcriptional coactivator and phosphatase 1 decreases expression EXP Dabigatran results in decreased expression of EYA1 mRNA CTD PMID:31711903 NCBI chr 8:71,197,433...71,548,104
Ensembl chr 8:71,197,433...71,592,025 		JBrowse link
G F2 coagulation factor II, thrombin decreases activity ISO
EXP		 Dabigatran results in decreased activity of F2 protein CTD PMID:17911567 PMID:25138021 NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
Ensembl chr11:46,719,196...46,739,506 		JBrowse link
G FGA fibrinogen alpha chain multiple interactions ISO Dabigatran inhibits the reaction [Dietary Fats results in increased cleavage of [FGA protein binds to FGB protein binds to FGG protein]] CTD PMID:25138021 NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,128...154,590,745 		JBrowse link
G FGB fibrinogen beta chain multiple interactions ISO Dabigatran inhibits the reaction [Dietary Fats results in increased cleavage of [FGA protein binds to FGB protein binds to FGG protein]] CTD PMID:25138021 NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
Ensembl chr 4:154,563,011...154,572,807 		JBrowse link
G FGF8 fibroblast growth factor 8 increases expression EXP Dabigatran results in increased expression of FGF8 mRNA CTD PMID:31711903 NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,130...101,780,369 		JBrowse link
G FGG fibrinogen gamma chain multiple interactions ISO Dabigatran inhibits the reaction [Dietary Fats results in increased cleavage of [FGA protein binds to FGB protein binds to FGG protein]] CTD PMID:25138021 NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967 		JBrowse link
G FOXC2 forkhead box C2 decreases expression EXP Dabigatran results in decreased expression of FOXC2 mRNA CTD PMID:31711903 NCBI chr16:86,566,829...86,569,728
Ensembl chr16:86,566,829...86,569,728 		JBrowse link
G GDNF glial cell derived neurotrophic factor multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in decreased expression of GDNF mRNA] CTD PMID:28585189 NCBI chr 5:37,812,677...37,840,044
Ensembl chr 5:37,812,677...37,840,041 		JBrowse link
G GFAP glial fibrillary acidic protein decreases expression ISO Dabigatran results in decreased expression of GFAP protein CTD PMID:27397090 NCBI chr17:44,903,159...44,915,552
Ensembl chr17:44,903,159...44,916,937 		JBrowse link
G HOXB9 homeobox B9 increases expression EXP Dabigatran results in increased expression of HOXB9 mRNA CTD PMID:31711903 NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358 		JBrowse link
G MEOX1 mesenchyme homeobox 1 decreases expression EXP Dabigatran results in decreased expression of MEOX1 mRNA CTD PMID:31711903 NCBI chr17:43,640,389...43,661,977
Ensembl chr17:43,640,389...43,661,922 		JBrowse link
G MERTK MER proto-oncogene, tyrosine kinase increases expression ISO Dabigatran results in increased expression of MERTK mRNA CTD PMID:27397090 NCBI chr 2:111,898,607...112,029,561
Ensembl chr 2:111,898,607...112,029,561 		JBrowse link
G NEUROG2 neurogenin 2 increases expression EXP Dabigatran results in increased expression of NEUROG2 mRNA CTD PMID:31711903 NCBI chr 4:112,513,516...112,516,180
Ensembl chr 4:112,513,516...112,516,180 		JBrowse link
G NR4A2 nuclear receptor subfamily 4 group A member 2 multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in decreased expression of NR4A2 mRNA] CTD PMID:28585189 NCBI chr 2:156,324,432...156,332,724
Ensembl chr 2:156,324,437...156,342,348 		JBrowse link
G OLIG3 oligodendrocyte transcription factor 3 increases expression EXP Dabigatran results in increased expression of OLIG3 mRNA CTD PMID:31711903 NCBI chr 6:137,492,199...137,494,394
Ensembl chr 6:137,492,199...137,494,394 		JBrowse link
G PAX3 paired box 3 decreases expression EXP Dabigatran results in decreased expression of PAX3 mRNA CTD PMID:31711903 NCBI chr 2:222,199,887...222,298,998
Ensembl chr 2:222,199,888...222,298,996
Ensembl chr 2:222,199,888...222,298,996 		JBrowse link
G PAX6 paired box 6 increases expression EXP Dabigatran results in increased expression of PAX6 mRNA CTD PMID:31711903 NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961 		JBrowse link
G PLP1 proteolipid protein 1 increases expression ISO Dabigatran results in increased expression of PLP1 mRNA CTD PMID:27397090 NCBI chr  X:103,776,506...103,792,619
Ensembl chr  X:103,773,718...103,792,619 		JBrowse link
G RCOR2 REST corepressor 2 multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in decreased expression of RCOR2 mRNA] CTD PMID:28585189 NCBI chr11:63,911,230...63,917,164
Ensembl chr11:63,911,230...63,917,164 		JBrowse link
G RET ret proto-oncogene multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in decreased expression of RET protein] CTD PMID:28585189 NCBI chr10:43,077,069...43,130,351
Ensembl chr10:43,077,064...43,130,351 		JBrowse link
G SLC18A2 solute carrier family 18 member A2 multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA] CTD PMID:28585189 NCBI chr10:117,241,114...117,279,430
Ensembl chr10:117,241,093...117,279,430 		JBrowse link
G SNCA synuclein alpha multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in increased expression of SNCA mRNA] CTD PMID:28585189 NCBI chr 4:89,724,099...89,838,324
Ensembl chr 4:89,700,345...89,838,315
Ensembl chr 4:89,700,345...89,838,315 		JBrowse link
G TCF15 transcription factor 15 decreases expression EXP Dabigatran results in decreased expression of TCF15 mRNA CTD PMID:31711903 NCBI chr20:604,257...610,309
Ensembl chr20:603,797...610,398 		JBrowse link
G TH tyrosine hydroxylase multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in decreased expression of TH mRNA] CTD PMID:28585189 NCBI chr11:2,163,929...2,174,081
Ensembl chr11:2,163,929...2,171,877
Ensembl chr11:2,163,929...2,171,877 		JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Dabigatran inhibits the reaction [Rotenone results in increased expression of TNF mRNA] CTD PMID:28585189 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G UNCX UNC homeobox decreases expression EXP Dabigatran results in decreased expression of UNCX mRNA CTD PMID:31711903 NCBI chr 7:1,232,872...1,237,326
Ensembl chr 7:1,232,872...1,237,326 		JBrowse link
debrisoquin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 decreases response to substance
increases metabolic processing
increases hydroxylation
affects metabolic processing
increases abundance
multiple interactions
decreases metabolic processing		 EXP CYP2D6 gene mutant form results in decreased susceptibility to Debrisoquin
CYP2D6 protein results in increased metabolism of Debrisoquin
CYP2D6 protein results in increased hydroxylation of Debrisoquin
CYP2D6 protein affects the metabolism of Debrisoquin; CYP2D6 protein polymorphism affects the metabolism of Debrisoquin
CYP2D6 gene mutant form results in increased abundance of Debrisoquin metabolite
CYP2D6 gene mutant form affects the metabolism of and affects the hydroxylation of Debrisoquin; Paroxetine inhibits the reaction [CYP2D6 gene mutant form results in decreased susceptibility to Debrisoquin]; Paroxetine inhibits the reaction [CYP2D6 gene mutant form results in increased abundance of Debrisoquin metabolite]
CYP2D6 gene mutant form results in decreased metabolism of Debrisoquin; CYP2D6 gene polymorphism results in decreased metabolism of Debrisoquin		 CTD PMID:3577206 PMID:6603386 PMID:8946814 PMID:11673748 PMID:11823760 PMID:12464242 PMID:17470523 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,881 		JBrowse link
diminazene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE2 angiotensin I converting enzyme 2 increases activity EXP Diminazene results in increased activity of ACE2 protein CTD PMID:21859683 NCBI chr  X:15,518,197...15,602,158
Ensembl chr  X:15,561,033...15,602,148
Ensembl chr  X:15,561,033...15,602,148 		JBrowse link
G ASIC5 acid sensing ion channel subunit family member 5 decreases activity ISO Diminazene results in decreased activity of ASIC5 protein CTD PMID:21828194 NCBI chr 4:155,829,699...155,867,303
Ensembl chr 4:155,829,729...155,866,277 		JBrowse link
dinotefuran term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CHRNB2 cholinergic receptor nicotinic beta 2 subunit multiple interactions ISO dinotefuran results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]; dinotefuran results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein] CTD PMID:16981889 PMID:25459289 NCBI chr 1:154,567,778...154,584,708
Ensembl chr 1:154,567,778...154,580,013 		JBrowse link
formetanate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Cartwright blood group) decreases activity ISO formetanate results in decreased activity of ACHE protein CTD PMID:19934164 PMID:21251949 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974 		JBrowse link
G BCHE butyrylcholinesterase multiple interactions ISO [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein CTD PMID:22649187 NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462 		JBrowse link
G HSPA1A heat shock protein family A (Hsp70) member 1A decreases expression EXP formetanate results in decreased expression of HSPA1A protein CTD PMID:16271832 NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP formetanate results in increased expression of HSPA5 protein CTD PMID:16271832 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,343 		JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 decreases expression EXP formetanate results in decreased expression of HSPA8 protein CTD PMID:16271832 NCBI chr11:123,057,489...123,062,366
Ensembl chr11:123,057,489...123,063,230 		JBrowse link
G NFE2L2 nuclear factor, erythroid 2 like 2 increases activity EXP formetanate results in increased activity of NFE2L2 protein CTD PMID:20143881 NCBI chr 2:177,230,303...177,265,131
Ensembl chr 2:177,227,595...177,392,697 		JBrowse link
guanethidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB4 ATP binding cassette subfamily B member 4 decreases activity EXP Guanethidine results in decreased activity of ABCB4 protein CTD PMID:28437613 NCBI chr 7:87,398,988...87,476,722
Ensembl chr 7:87,401,697...87,480,435
Ensembl chr 7:87,401,697...87,480,435 		JBrowse link
G ACP5 acid phosphatase 5, tartrate resistant affects expression
increases expression		 ISO Guanethidine affects the expression of ACP5 protein
Guanethidine results in increased expression of ACP5 mRNA		 CTD PMID:14527964 NCBI chr19:11,574,660...11,578,983
Ensembl chr19:11,574,660...11,579,008 		JBrowse link
G CTSK cathepsin K increases expression
affects expression		 ISO Guanethidine results in increased expression of CTSK mRNA
Guanethidine affects the expression of CTSK protein		 CTD PMID:14527964 NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,796,208...150,808,260
Ensembl chr 1:150,796,208...150,808,260 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 multiple interactions ISO Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] CTD PMID:16510159 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G MMP13 matrix metallopeptidase 13 increases expression ISO Guanethidine results in increased expression of MMP13 mRNA CTD PMID:14527964 NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732 		JBrowse link
G NPY neuropeptide Y decreases expression
decreases secretion		 ISO
EXP		 Guanethidine results in decreased expression of NPY protein
Guanethidine results in decreased secretion of NPY protein		 CTD PMID:9460767 PMID:14527964 PMID:15003356 NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862 		JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions ISO Guanethidine inhibits the reaction [Kainic Acid results in increased expression of SERPINE1 mRNA] CTD PMID:15850565 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247 		JBrowse link
G TH tyrosine hydroxylase decreases expression ISO Guanethidine results in decreased expression of TH protein CTD PMID:9460767 NCBI chr11:2,163,929...2,174,081
Ensembl chr11:2,163,929...2,171,877
Ensembl chr11:2,163,929...2,171,877 		JBrowse link
G VIP vasoactive intestinal peptide decreases expression ISO Guanethidine results in decreased expression of VIP protein CTD PMID:14527964 NCBI chr 6:152,750,797...152,759,765
Ensembl chr 6:152,750,797...152,759,765 		JBrowse link
guanidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALB albumin multiple interactions
affects folding
decreases folding		 EXP Guanidine affects the folding of [acrylodan binds to ALB protein]; Guanidine inhibits the reaction [prodan binds to ALB protein]
Guanidine affects the folding of ALB protein
Guanidine results in decreased folding of ALB protein		 CTD PMID:12044178 PMID:15353599 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482 		JBrowse link
G SLC22A16 solute carrier family 22 member 16 multiple interactions EXP Guanidine inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium] CTD PMID:15963465 NCBI chr 6:110,424,587...110,476,674
Ensembl chr 6:110,424,687...110,476,641 		JBrowse link
G SLC22A3 solute carrier family 22 member 3 multiple interactions
increases uptake		 ISO
EXP		 Guanidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
Guanidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog]
SLC22A3 protein results in increased uptake of Guanidine
Guanidine inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium]		 CTD PMID:9830022 PMID:10966924 NCBI chr 6:160,348,378...160,454,982
Ensembl chr 6:160,348,378...160,452,577 		JBrowse link
G SLC47A1 solute carrier family 47 member 1 multiple interactions EXP Guanidine affects the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034 		JBrowse link
G SLC47A2 solute carrier family 47 member 2 multiple interactions EXP Guanidine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 NCBI chr17:19,678,313...19,719,598
Ensembl chr17:19,678,288...19,718,979 		JBrowse link
G SOD1 superoxide dismutase 1 decreases folding EXP Guanidine results in decreased folding of SOD1 protein mutant form CTD PMID:23612299 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,622...31,668,931
Ensembl chr21:31,659,622...31,668,931 		JBrowse link
melagatran term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G F2 coagulation factor II, thrombin multiple interactions EXP melagatran binds to and results in decreased activity of F2 protein CTD PMID:16084352 NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
Ensembl chr11:46,719,196...46,739,506 		JBrowse link
N'-(2,4-dimethylphenyl)-N-methylformamidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CAT catalase multiple interactions
decreases expression		 ISO KEAP1 protein affects the reaction [U 40481 results in decreased expression of CAT protein] CTD PMID:31029719 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression ISO U 40481 results in increased expression of CYP1A1 protein CTD PMID:31029719 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases expression ISO U 40481 results in increased expression of CYP1A2 protein CTD PMID:31029719 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 increases expression ISO U 40481 results in increased expression of CYP2E1 protein CTD PMID:31029719 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220 		JBrowse link
G GCG glucagon increases secretion ISO U 40481 results in increased secretion of GCG protein CTD PMID:10582558 NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404 		JBrowse link
G KEAP1 kelch like ECH associated protein 1 increases expression
multiple interactions		 ISO U 40481 results in increased expression of KEAP1 protein
KEAP1 protein affects the reaction [U 40481 results in decreased expression of CAT protein]; KEAP1 protein affects the reaction [U 40481 results in decreased expression of NFE2L2 protein]; KEAP1 protein affects the reaction [U 40481 results in decreased expression of NQO1 protein]; KEAP1 protein affects the reaction [U 40481 results in decreased expression of SOD1 protein]		 CTD PMID:31029719 NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558 		JBrowse link
G NFE2L2 nuclear factor, erythroid 2 like 2 multiple interactions
decreases expression		 ISO KEAP1 protein affects the reaction [U 40481 results in decreased expression of NFE2L2 protein] CTD PMID:31029719 NCBI chr 2:177,230,303...177,265,131
Ensembl chr 2:177,227,595...177,392,697 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression		 ISO KEAP1 protein affects the reaction [U 40481 results in decreased expression of NQO1 protein] CTD PMID:31029719 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G SOD1 superoxide dismutase 1 decreases expression
multiple interactions		 ISO U 40481 results in decreased expression of SOD1 protein
KEAP1 protein affects the reaction [U 40481 results in decreased expression of SOD1 protein]		 CTD PMID:31029719 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,622...31,668,931
Ensembl chr21:31,659,622...31,668,931 		JBrowse link
N-[3-(aminomethyl)benzyl]acetamidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKT2 AKT serine/threonine kinase 2 affects response to substance ISO AKT2 protein affects the susceptibility to N-(3-(aminomethyl)benzyl)acetamidine CTD PMID:21964073 NCBI chr19:40,230,317...40,285,531
Ensembl chr19:40,230,317...40,285,536 		JBrowse link
G BNIP3 BCL2 interacting protein 3 multiple interactions ISO [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 NCBI chr10:131,967,683...131,982,013
Ensembl chr10:131,966,455...131,982,013 		JBrowse link
G CAV1 caveolin 1 multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein] CTD PMID:18717816 NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,525,001...116,561,184
Ensembl chr 7:116,525,001...116,561,184 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions ISO N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein] CTD PMID:15542068 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 multiple interactions ISO N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] CTD PMID:15542068 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA] CTD PMID:18206661 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398 		JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions ISO N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxidopamine results in increased expression of HMOX1 protein] CTD PMID:21397656 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,207
Ensembl chr22:35,380,361...35,394,207 		JBrowse link
G IFNG interferon gamma multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased activity of NOS2 protein] CTD PMID:11076874 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740 		JBrowse link
G IL1B interleukin 1 beta multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased activity of NOS2 protein] CTD PMID:11076874 NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G ITGB2 integrin subunit beta 2 multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP2A protein] CTD PMID:16963453 NCBI chr21:44,885,949...44,928,815
Ensembl chr21:44,885,953...44,931,989 		JBrowse link
G LEPR leptin receptor increases response to substance ISO LEPR gene mutant form results in increased susceptibility to N-(3-(aminomethyl)benzyl)acetamidine CTD PMID:30689673 NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559 		JBrowse link
G MPO myeloperoxidase multiple interactions ISO N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Indomethacin results in increased activity of MPO protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] CTD PMID:11504810 PMID:11713966 NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions
decreases activity		 EXP
ISO		 [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [fluvastatin results in increased abundance of Nitric Oxide]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased activity of NOS2 protein]
[N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] which results in increased susceptibility to endothelium-dependent hyperpolarization factor; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Potassium Cyanide results in increased expression of NOS2 protein]
[N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased chemical synthesis of Reactive Oxygen Species]; [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein]		 CTD PMID:11076874 PMID:11134894 PMID:16461118 PMID:16933320 PMID:19442826 PMID:19951519 PMID:20035746 PMID:20497644 PMID:20549418 PMID:23061969 PMID:24964743 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G RAP1A RAP1A, member of RAS oncogene family multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein] CTD PMID:16963453 NCBI chr 1:111,542,009...111,716,695
Ensembl chr 1:111,542,218...111,716,691 		JBrowse link
G RAP2A RAP2A, member of RAS oncogene family multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP2A protein] CTD PMID:16963453 NCBI chr13:97,434,169...97,469,128
Ensembl chr13:97,434,169...97,469,128 		JBrowse link
G TFRC transferrin receptor multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [fluvastatin results in decreased expression of TFRC protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [GGTI 298 results in decreased expression of TFRC protein] CTD PMID:24964743 NCBI chr 3:196,018,694...196,082,123
Ensembl chr 3:196,027,183...196,082,096 		JBrowse link
G TNF tumor necrosis factor multiple interactions EXP N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased activity of NOS2 protein] CTD PMID:11076874 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
N-methyl-N'-nitro-N-nitrosoguanidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ABL1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ABL1 mRNA CTD PMID:19840844 NCBI chr 9:130,713,881...130,887,675
Ensembl chr 9:130,713,016...130,887,675 		JBrowse link
G ACOX2 acyl-CoA oxidase 2 decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of ACOX2 mRNA CTD PMID:15120970 NCBI chr 3:58,505,136...58,537,196
Ensembl chr 3:58,505,136...58,537,283 		JBrowse link
G ADAM10 ADAM metallopeptidase domain 10 increases expression EXP Methylnitronitrosoguanidine results in increased expression of ADAM10 mRNA CTD PMID:12634122 NCBI chr15:58,588,809...58,749,707
Ensembl chr15:58,588,809...58,749,791 		JBrowse link
G AGT angiotensinogen multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of AGT mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of AGT mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of AGT mRNA CTD PMID:19840844 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,702,523...230,714,122 		JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 multiple interactions
increases localization		 EXP benzamide inhibits the reaction [Methylnitronitrosoguanidine results in increased localization of AIFM1 protein]; phenanthridone inhibits the reaction [Methylnitronitrosoguanidine results in increased localization of AIFM1 protein] CTD PMID:15589979 NCBI chr  X:130,129,362...130,165,841
Ensembl chr  X:130,124,666...130,165,879
Ensembl chr  X:130,124,666...130,165,879 		JBrowse link
G ALB albumin decreases secretion ISO Methylnitronitrosoguanidine results in decreased secretion of ALB protein CTD PMID:15772367 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482 		JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of ALDH1A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of ALDH1A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of ALDH1A1 mRNA CTD PMID:19840844 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442 		JBrowse link
G ALPL alkaline phosphatase, biomineralization associated increases expression EXP Methylnitronitrosoguanidine results in increased expression of ALPL mRNA CTD PMID:12634122 NCBI chr 1:21,508,984...21,578,412
Ensembl chr 1:21,509,397...21,578,410 		JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of AMBP mRNA CTD PMID:12773770 NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328 		JBrowse link
G ANXA5 annexin A5 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ANXA5 mRNA CTD PMID:19840844 NCBI chr 4:121,667,946...121,696,994
Ensembl chr 4:121,667,946...121,696,995 		JBrowse link
G APAF1 apoptotic peptidase activating factor 1 affects response to substance
decreases expression
multiple interactions		 ISO APAF1 protein affects the susceptibility to Methylnitronitrosoguanidine
Methylnitronitrosoguanidine results in decreased expression of APAF1 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein]		 CTD PMID:16019050 PMID:20434464 NCBI chr12:98,645,141...98,735,433
Ensembl chr12:98,645,141...98,735,433
Ensembl chr12:98,645,141...98,735,433 		JBrowse link
G APC APC regulator of WNT signaling pathway increases expression EXP Methylnitronitrosoguanidine results in increased expression of APC mRNA CTD PMID:12634122 NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,498...112,846,239 		JBrowse link
G APP amyloid beta precursor protein multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of APP mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of APP mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of APP mRNA CTD PMID:19840844 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,550...26,171,128 		JBrowse link
G ARAF A-Raf proto-oncogene, serine/threonine kinase increases expression EXP Methylnitronitrosoguanidine results in increased expression of ARAF mRNA CTD PMID:12634122 NCBI chr  X:47,561,205...47,571,908
Ensembl chr  X:47,561,100...47,571,920 		JBrowse link
G ATM ATM serine/threonine kinase increases response to substance ISO ATM gene mutant form results in increased susceptibility to Methylnitronitrosoguanidine CTD PMID:15010311 NCBI chr11:108,222,484...108,369,102
Ensembl chr11:108,222,832...108,369,102
Ensembl chr11:108,222,832...108,369,102 		JBrowse link
G ATP1B3 ATPase Na+/K+ transporting subunit beta 3 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of ATP1B3 mRNA CTD PMID:12634122 NCBI chr 3:141,876,643...141,926,549
Ensembl chr 3:141,876,124...141,926,549 		JBrowse link
G ATR ATR serine/threonine kinase multiple interactions EXP ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein] CTD PMID:26921499 NCBI chr 3:142,449,235...142,578,793
Ensembl chr 3:142,449,007...142,578,733 		JBrowse link
G AXL AXL receptor tyrosine kinase increases expression EXP Methylnitronitrosoguanidine results in increased expression of AXL mRNA CTD PMID:12634122 NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766 		JBrowse link
G BAD BCL2 associated agonist of cell death decreases expression
decreases phosphorylation
multiple interactions		 ISO
EXP		 Methylnitronitrosoguanidine results in decreased expression of BAD mRNA
Methylnitronitrosoguanidine results in decreased phosphorylation of BAD protein
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of BAD protein]
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA]		 CTD PMID:17828454 PMID:20434464 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704 		JBrowse link
G BAG1 BAG cochaperone 1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of BAG1 mRNA CTD PMID:12634122 NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720 		JBrowse link
G BAK1 BCL2 antagonist/killer 1 multiple interactions EXP BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 NCBI chr 6:33,572,552...33,580,296
Ensembl chr 6:33,572,547...33,580,293 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions
decreases expression		 ISO
EXP		 [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BAX protein
Methylnitronitrosoguanidine results in decreased expression of BAX mRNA; Methylnitronitrosoguanidine results in decreased expression of BAX protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein]
BAX protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib]		 CTD PMID:16030430 PMID:18376143 PMID:20434464 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BCAT2 branched chain amino acid transaminase 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BCAT2 mRNA CTD PMID:19840844 NCBI chr19:48,795,064...48,811,029
Ensembl chr19:48,795,062...48,811,029 		JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression
increases expression
multiple interactions		 ISO Methylnitronitrosoguanidine results in decreased expression of BCL2 protein
Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA; Methylnitronitrosoguanidine results in increased expression of BCL2 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein; [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]		 CTD PMID:16019050 PMID:16030430 PMID:20434464 NCBI chr18:63,123,346...63,320,280
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G BCL2L1 BCL2 like 1 multiple interactions
increases expression		 EXP
ISO		 BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib]
Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA]		 CTD PMID:18376143 PMID:20434464 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989 		JBrowse link
G BCL2L11 BCL2 like 11 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,445 		JBrowse link
G BDNF brain derived neurotrophic factor increases expression ISO Methylnitronitrosoguanidine results in increased expression of BDNF mRNA CTD PMID:15120970 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058 		JBrowse link
G BGN biglycan multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of BGN mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of BGN mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BGN mRNA CTD PMID:19840844 NCBI chr  X:153,494,980...153,509,546
Ensembl chr  X:153,494,980...153,509,546 		JBrowse link
G BID BH3 interacting domain death agonist multiple interactions
decreases expression		 ISO Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA] CTD PMID:20434464 NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770 		JBrowse link
G BIRC2 baculoviral IAP repeat containing 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of BIRC2 mRNA CTD PMID:12634122 NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670 		JBrowse link
G BLVRB biliverdin reductase B multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA CTD PMID:19840844 NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764 		JBrowse link
G BMP4 bone morphogenetic protein 4 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of BMP4 mRNA CTD PMID:12773770 NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761 		JBrowse link
G BRCA1 BRCA1 DNA repair associated increases expression EXP Methylnitronitrosoguanidine results in increased expression of BRCA1 mRNA CTD PMID:12634122 NCBI chr17:43,044,295...43,125,364
Ensembl chr17:43,044,295...43,170,245 		JBrowse link
G BRCA2 BRCA2 DNA repair associated increases expression EXP Methylnitronitrosoguanidine results in increased expression of BRCA2 mRNA CTD PMID:12634122 NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
Ensembl chr13:32,315,086...32,400,268 		JBrowse link
G BTG2 BTG anti-proliferation factor 2 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of BTG2 protein CTD PMID:24821435 NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602 		JBrowse link
G C1QB complement C1q B chain increases expression ISO Methylnitronitrosoguanidine results in increased expression of C1QB mRNA CTD PMID:15120970 NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637 		JBrowse link
G C1S complement C1s increases expression ISO Methylnitronitrosoguanidine results in increased expression of C1S mRNA CTD PMID:15120970 NCBI chr12:7,060,718...7,071,032
Ensembl chr12:6,988,259...7,071,032 		JBrowse link
G CALM1 calmodulin 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CALM1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CALM1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CALM1 mRNA CTD PMID:19840844 NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268 		JBrowse link
G CASP3 caspase 3 increases activity
decreases expression
multiple interactions		 EXP
ISO		 Methylnitronitrosoguanidine results in increased activity of CASP3 protein
Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA; Methylnitronitrosoguanidine results in decreased expression of CASP3 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Methylnitronitrosoguanidine results in increased activity of CASP3 protein]
[Methylnitronitrosoguanidine co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased activity of CASP3 protein; [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein]		 CTD PMID:15589979 PMID:16019050 PMID:16030430 PMID:17428624 PMID:20434464 PMID:24476502 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509 		JBrowse link
G CASP4 caspase 4 increases expression EXP Methylnitronitrosoguanidine results in increased expression of CASP4 mRNA CTD PMID:12634122 NCBI chr11:104,942,866...104,968,596
Ensembl chr11:104,942,866...104,969,366 		JBrowse link
G CASP8 caspase 8 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein; [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] CTD PMID:16030430 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,287,711 		JBrowse link
G CASP9 caspase 9 increases activity
decreases expression
multiple interactions		 EXP
ISO		 Methylnitronitrosoguanidine results in increased activity of CASP9 protein
Methylnitronitrosoguanidine results in decreased expression of CASP9 protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein]		 CTD PMID:15589979 PMID:16019050 PMID:20434464 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534 		JBrowse link
G CBX5 chromobox 5 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of CBX5 mRNA CTD PMID:12634122 NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133 		JBrowse link
G CCNA1 cyclin A1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of CCNA1 mRNA CTD PMID:12634122 NCBI chr13:36,430,488...36,442,870
Ensembl chr13:36,431,520...36,442,870 		JBrowse link
G CCNB1 cyclin B1 multiple interactions
decreases expression
increases expression		 ISO Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA]
Methylnitronitrosoguanidine results in decreased expression of CCNB1 mRNA
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCNB1 mRNA		 CTD PMID:11516527 PMID:12135628 PMID:19851710 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245 		JBrowse link
G CCND1 cyclin D1 multiple interactions
increases expression		 ISO Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA]
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCND1 protein
Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA; Methylnitronitrosoguanidine results in increased expression of CCND1 protein		 CTD PMID:12135628 PMID:19851710 PMID:21628965 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474 		JBrowse link
G CCNG1 cyclin G1 increases expression ISO Methylnitronitrosoguanidine results in increased expression of CCNG1 mRNA CTD PMID:11516527 NCBI chr 5:163,437,571...163,448,199
Ensembl chr 5:163,437,569...163,446,151 		JBrowse link
G CCNH cyclin H increases expression EXP Methylnitronitrosoguanidine results in increased expression of CCNH mRNA CTD PMID:12634122 NCBI chr 5:87,311,471...87,412,971
Ensembl chr 5:87,318,416...87,412,930 		JBrowse link
G CCT2 chaperonin containing TCP1 subunit 2 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCT2 mRNA CTD PMID:19840844 NCBI chr12:69,585,459...69,601,570
Ensembl chr12:69,585,426...69,601,570 		JBrowse link
G CD59 CD59 molecule (CD59 blood group) increases mutagenesis EXP Methylnitronitrosoguanidine results in increased mutagenesis of CD59 protein CTD PMID:17045307 NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,491
Ensembl chr11:33,703,010...33,736,491 		JBrowse link
G CD9 CD9 molecule multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CD9 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CD9 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD9 mRNA CTD PMID:19840844 NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271 		JBrowse link
G CDH1 cadherin 1 multiple interactions
decreases expression		 ISO geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein] CTD PMID:28428697 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,541 		JBrowse link
G CDH8 cadherin 8 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of CDH8 mRNA CTD PMID:12634122 NCBI chr16:61,640,398...62,036,446
Ensembl chr16:61,647,242...62,037,035 		JBrowse link
G CDK4 cyclin dependent kinase 4 multiple interactions
increases expression		 ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein
Methylnitronitrosoguanidine results in increased expression of CDK4 protein		 CTD PMID:12135628 PMID:21628965 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013 		JBrowse link
G CDK5 cyclin dependent kinase 5 increases expression EXP Methylnitronitrosoguanidine results in increased expression of CDK5 mRNA CTD PMID:12634122 NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A decreases expression
multiple interactions		 EXP
ISO		 Methylnitronitrosoguanidine results in decreased expression of CDKN1A mRNA
Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein]		 CTD PMID:12634122 PMID:19851710 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,339
Ensembl chr 6:36,676,460...36,687,339 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B decreases expression
multiple interactions
increases expression		 ISO Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA
Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein]; Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA]		 CTD PMID:11516527 PMID:12135628 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,715,058...12,722,369 		JBrowse link
G CEP43 centrosomal protein 43 increases expression EXP Methylnitronitrosoguanidine results in increased expression of CEP43 mRNA CTD PMID:12634122 NCBI chr 6:166,999,397...167,052,718
Ensembl chr 6:166,999,317...167,094,789 		JBrowse link
G CHEK1 checkpoint kinase 1 multiple interactions EXP CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein] CTD PMID:26921499 NCBI chr11:125,624,910...125,676,255
Ensembl chr11:125,625,665...125,676,255 		JBrowse link
G CHEK2 checkpoint kinase 2 multiple interactions EXP CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein] CTD PMID:26921499 NCBI chr22:28,687,743...28,741,866
Ensembl chr22:28,687,743...28,742,422 		JBrowse link
G CKB creatine kinase B decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of CKB mRNA CTD PMID:12634122 NCBI chr14:103,519,667...103,522,833
Ensembl chr14:103,519,667...103,522,833 		JBrowse link
G CLTA clathrin light chain A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CLTA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CLTA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CLTA mRNA CTD PMID:19840844 NCBI chr 9:36,190,855...36,212,059
Ensembl chr 9:36,190,856...36,304,781 		JBrowse link
G COL1A2 collagen type I alpha 2 chain multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL1A2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL1A2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL1A2 mRNA CTD PMID:19840844 NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227 		JBrowse link
G COL6A1 collagen type VI alpha 1 chain multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL6A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL6A1 mRNA CTD PMID:19840844 NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,769...46,005,050
Ensembl chr21:45,981,769...46,005,050 		JBrowse link
G COL8A1 collagen type VIII alpha 1 chain multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL8A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL8A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL8A1 mRNA CTD PMID:19840844 NCBI chr 3:99,638,594...99,799,217
Ensembl chr 3:99,638,475...99,799,226 		JBrowse link
G COX6A1 cytochrome c oxidase subunit 6A1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of COX6A1 mRNA CTD PMID:19840844 NCBI chr12:120,438,113...120,440,730
Ensembl chr12:120,438,090...120,440,737 		JBrowse link
G COX8A cytochrome c oxidase subunit 8A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of COX8A mRNA CTD PMID:19840844 NCBI chr11:63,974,620...63,976,543
Ensembl chr11:63,974,620...63,976,543 		JBrowse link
G CTNNB1 catenin beta 1 increases expression
multiple interactions		 ISO Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA]		 CTD PMID:28428697 NCBI chr 3:41,199,422...41,240,445
Ensembl chr 3:41,194,741...41,260,096 		JBrowse link
G CTSB cathepsin B multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of CTSB mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of CTSB mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CTSB mRNA CTD PMID:19840844 NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,448
Ensembl chr 8:11,842,524...11,869,448 		JBrowse link
G CTSL cathepsin L multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CTSL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CTSL mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CTSL mRNA CTD PMID:19840844 NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,726,109...87,731,469
Ensembl chr 9:87,726,109...87,731,469 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CXCL12 mRNA CTD PMID:19840844 NCBI chr10:44,292,088...44,385,097
Ensembl chr10:44,370,165...44,386,493 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of CXCR4 mRNA CTD PMID:12634122 NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,118,149 		JBrowse link
G CYB561D2 cytochrome b561 family member D2 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of CYB561D2 mRNA CTD PMID:12634122 NCBI chr 3:50,350,862...50,368,197
Ensembl chr 3:50,350,845...50,358,460
Ensembl chr 3:50,350,845...50,358,460
Ensembl chr 3:50,350,845...50,358,460 		JBrowse link
G CYCS cytochrome c, somatic multiple interactions
decreases expression		 ISO Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein]
Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA; Methylnitronitrosoguanidine results in decreased expression of CYCS protein		 CTD PMID:20434464 NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260 		JBrowse link
G DAB2 DAB adaptor protein 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of DAB2 mRNA CTD PMID:12634122 PMID:12773770 NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300 		JBrowse link
G DCN decorin decreases expression ISO Methylnitronitrosoguanidine results in decreased expression of DCN mRNA CTD PMID:15120970 NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
Ensembl chr12:91,140,484...91,183,217 		JBrowse link
G DEAF1 DEAF1 transcription factor decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of DEAF1 mRNA CTD PMID:12634122 NCBI chr11:644,220...707,083
Ensembl chr11:644,233...706,715 		JBrowse link
G DEK DEK proto-oncogene increases expression EXP Methylnitronitrosoguanidine results in increased expression of DEK mRNA CTD PMID:12634122 NCBI chr 6:18,223,860...18,264,541
Ensembl chr 6:18,223,860...18,264,548 		JBrowse link
G DLG1 discs large MAGUK scaffold protein 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of DLG1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of DLG1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of DLG1 mRNA CTD PMID:19840844 NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330 		JBrowse link
G DSTN destrin, actin depolymerizing factor increases expression EXP Methylnitronitrosoguanidine results in increased expression of DSTN mRNA CTD PMID:12634122 NCBI chr20:17,569,173...17,609,919
Ensembl chr20:17,570,075...17,609,919 		JBrowse link
G DUT deoxyuridine triphosphatase affects localization
increases secretion		 EXP Methylnitronitrosoguanidine affects the localization of DUT protein
Methylnitronitrosoguanidine results in increased secretion of DUT protein		 CTD PMID:21658424 NCBI chr15:48,329,991...48,343,373
Ensembl chr15:48,331,011...48,343,373 		JBrowse link
G E2F1 E2F transcription factor 1 multiple interactions
increases expression		 EXP ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein results in increased expression of RRM2 mRNA] CTD PMID:26921499 NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385 		JBrowse link
G E2F3 E2F transcription factor 3 multiple interactions EXP [[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; [Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHIR-124 inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; E2F3 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]] CTD PMID:26921499 NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714 		JBrowse link
G EGF epidermal growth factor affects activity
multiple interactions		 EXP Methylnitronitrosoguanidine affects the activity of EGF protein
Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein]; Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]		 CTD PMID:15708576 NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766 		JBrowse link
G EGFR epidermal growth factor receptor affects localization
multiple interactions		 EXP Methylnitronitrosoguanidine affects the localization of EGFR protein
Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]		 CTD PMID:15708576 NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628 		JBrowse link
G EGR1 early growth response 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA CTD PMID:19840844 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303 		JBrowse link
G EIF1 eukaryotic translation initiation factor 1 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EIF1 mRNA CTD PMID:19840844 NCBI chr17:41,688,885...41,692,668
Ensembl chr17:41,688,885...41,692,668 		JBrowse link
G EIF3E eukaryotic translation initiation factor 3 subunit E increases expression EXP Methylnitronitrosoguanidine results in increased expression of EIF3E mRNA CTD PMID:12634122 NCBI chr 8:108,201,216...108,248,734
Ensembl chr 8:108,201,216...108,435,333
Ensembl chr 8:108,201,216...108,435,333 		JBrowse link
G EIF5 eukaryotic translation initiation factor 5 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of EIF5 mRNA CTD PMID:12634122 NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025 		JBrowse link
G EIF5A eukaryotic translation initiation factor 5A multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EIF5A mRNA CTD PMID:19840844 NCBI chr17:7,306,999...7,312,463
Ensembl chr17:7,306,999...7,312,463 		JBrowse link
G ELK3 ETS transcription factor ELK3 increases expression EXP Methylnitronitrosoguanidine results in increased expression of ELK3 mRNA CTD PMID:12634122 NCBI chr12:96,194,375...96,269,824
Ensembl chr12:96,194,375...96,269,824 		JBrowse link
G EMP1 epithelial membrane protein 1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of EMP1 mRNA CTD PMID:12634122 NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941 		JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of ENPP2 mRNA CTD PMID:15120970 NCBI chr 8:119,557,085...119,673,404
Ensembl chr 8:119,557,086...119,673,453 		JBrowse link
G EPCAM epithelial cell adhesion molecule increases expression EXP Methylnitronitrosoguanidine results in increased expression of EPCAM mRNA CTD PMID:12634122 NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601 		JBrowse link
G EPHA1 EPH receptor A1 increases expression EXP Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA CTD PMID:12634122 NCBI chr 7:143,390,813...143,408,865
Ensembl chr 7:143,390,289...143,408,856 		JBrowse link
G EPHB3 EPH receptor B3 decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of EPHB3 mRNA CTD PMID:12634122 NCBI chr 3:184,561,785...184,582,408
Ensembl chr 3:184,561,785...184,582,408 		JBrowse link
G EPS8 epidermal growth factor receptor pathway substrate 8 multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EPS8 mRNA CTD PMID:19840844 NCBI chr12:15,620,134...15,789,388
Ensembl chr12:15,620,134...15,882,329 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 increases expression EXP Methylnitronitrosoguanidine results in increased expression of ERBB2 mRNA CTD PMID:12634122 NCBI chr17:39,688,094...39,728,660
Ensembl chr17:39,687,914...39,730,426 		JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 increases expression EXP Methylnitronitrosoguanidine results in increased expression of ERBB4 mRNA CTD PMID:12634122 NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841 		JBrowse link
G ESR2 estrogen receptor 2 increases expression ISO Methylnitronitrosoguanidine results in increased expression of ESR2 mRNA; Methylnitronitrosoguanidine results in increased expression of ESR2 protein CTD PMID:21628965 PMID:22330348 NCBI chr14:64,226,707...64,338,631
Ensembl chr14:64,084,232...64,338,112 		JBrowse link
G ETS1 ETS proto-oncogene 1, transcription factor increases expression EXP Methylnitronitrosoguanidine results in increased expression of ETS1 mRNA CTD PMID:12634122 NCBI chr11:128,458,765...128,587,593
Ensembl chr11:128,458,761...128,587,558 		JBrowse link
G FASLG Fas ligand decreases expression EXP Methylnitronitrosoguanidine results in decreased expression of FASLG protein CTD PMID:24821435 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876 		JBrowse link
G FASN fatty acid synthase increases expression EXP Methylnitronitrosoguanidine results in increased expression of FASN mRNA CTD PMID:12634122 NCBI chr17:82,078,338...82,098,303
Ensembl chr17:82,078,338...82,098,294 		JBrowse link
G FAU FAU ubiquitin like and ribosomal protein S30 fusion multiple interactions ISO [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of FAU mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of FAU mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FAU mRNA CTD PMID:19840844 NCBI chr11:65,120,630...65,122,134
Ensembl chr11:65,120,630...65,122,177 		JBrowse link
G FCER1A Fc fragment of IgE receptor Ia increases expression ISO Methylnitronitrosoguanidine results in increased expression of FCER1A mRNA CTD PMID:15120970 NCBI chr 1:159,283,575...159,308,202
Ensembl chr 1:159,289,714...159,308,224 		JBrowse link
G FCGR2A Fc fragment of IgG receptor IIa increases expression ISO Methylnitronitrosoguanidine results in increased expression of FCGR3 mRNA CTD PMID:15120970 NCBI chr 1:161,505,430...161,524,048
Ensembl chr 1:161,505,430...161,524,013 		JBrowse link
G FCGRT Fc fragment of IgG receptor and transporter